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Tissue engineering is considered as a potential therapeutic option for the 
regeneration of damaged cartilage tissue.  Bioreactors are devices engineered 
for the application of specific stimuli on tissue constructs to promote matrix 
deposition.  Currently, tissue engineered cartilage has lower matrix content and 
material properties compared to native tissue.  Establishing relationships 
between culture conditions and tissue composition is important for tissue 
engineering. This study identifies certain specific bioreactor conditions that 
enhance construct extracellular matrix production.  Experiments are carried out 
based on the hypothesis that bioreactor conditions specifically, fluid induced 
shear stress and oxygen tension affect construct extracellular matrix deposition. 
The results suggest that a combination of biochemical and mechanical stimuli as 
opposed to either stimulus alone may be required to enhance construct 
extracellular matrix deposition. In order to increase nutrient transport to the 
construct and use multiple fluid flow regimes, a perfusion shear flow bioreactor 
was designed and a prototype built.  The constructs cultured in this bioreactor 
showed robust cell proliferation and extracellular matrix deposition over short 
term (14 day) and long term (35 day) cultures.  
In summary, this work focuses on specific bioreactor culture conditions 







One in seven Americans suffers from a musculoskeletal impairment and 
as many as $215 billion are spent annually for the treatment of these conditions.  
Among these conditions, arthritis is the most commonly reported problem.  As 
many as 17 million people were reported to be suffering from knee problems in 
the year 2000 alone (2004; Praemer et al., 1999).  The most common type of 
impairment results from osteoarthritis, where the cartilage covering the ends of 
the joint gradually wears away, exposing the bone ends.  This makes joint motion 
difficult and painful.  Self-repair of cartilage is limited and the repair tissue that is 
formed is a combination of hyaline and fibro-cartilage.  This repair tissue does 
not perform as well as hyaline cartilage and degrades over time.  Furthermore, 
the repair tissue usually lacks the mechanical properties and ultrastructure to 
ensure long-term stability (Lonner, 2004).  Current therapies for osteoarthritis 
include subchondral shaving, autologous grafts, and mesenchymal cell 
regeneration therapy.  Some of these therapies work in the short term for small 
lesions.  However, no long term treatment strategy is available for the repair of 
cartilage in full thickness lesions damaged due to osteoarthritis and related joint 
disorders. 
 Tissue engineering is considered as a potential therapeutic option for the 
regeneration of damaged tissue.  Tissue engineering can perhaps be best 
described as the use of a combination of cells, engineering materials, and 
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suitable biochemical and mechanical factors to improve or replace biological 
tissue to effect the advancement of medicine.  A tissue engineered cartilage 
template or construct could potentially repair full thickness defects in a 
diarthrodial joint.  However, as in the case of most tissue engineered substitutes, 
the requirements of culture conditions and the definition of suitable implants are 
still open to debate.  In the case of cartilage tissue engineering, this challenge is 
only enhanced by the complex architecture and material properties of native 
cartilage.  
 Native cartilage is a highly organized tissue with a well-defined zonal cell 
morphology and matrix fibril organization.  The tissue has low cell volume and an 
abundance of extracellular matrix.  Cartilage exhibits a zone specific organization 
of matrix fibrils that is responsible for the material properties of the tissue.  The 
functional ability of cartilage depends on the organization and quantity of 
extracellular matrix and its material properties.  Thus, long-term successful repair 
or regeneration of articular cartilage in synovial or weight bearing joints, such as 
the knee or hip, is a formidable task not currently achievable through surgical and 
non-surgical treatments.  One approach to tissue engineering of cartilage is to 
seed chondrocytes or mesenchymal progenitor cells onto biodegradable polymer 
scaffolds in a culture environment that promotes the development of tissue 
suitable for implantation.   
Bioreactors are devices engineered for the application of specific stimuli 
(mechanical and biochemical) on tissue constructs to promote matrix deposition.  
Currently, engineered tissue has lower matrix content and material properties 
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compared to native tissue.  Very few studies have assessed the matrix 
organization within engineered tissue constructs.  The bioreactor environment 
provides the necessary biochemical and mechanical conditions (e.g. shear 
stress, hydrodynamic loading, perfusion) to stimulate chondrocytes to synthesize 
and deposit extracellular matrix. The application of complex, multi-factorial 
bioreactor environments could, in theory, provide structural materials suitable for 
implantation in vivo.  
Many bioprocessing stimuli promote cartilage extracellular matrix 
deposition.  In vivo, cartilage experiences shear stress and compression as 
primary forces.  In vitro, shear stress affects cartilage matrix deposition.  
However, the degree of stimulation that can be achieved using shear stress is 
not known.  Establishing relationships between culture conditions and tissue 
architecture will lead to the development of tissue engineered cartilage with 
improved function for in vivo performance. This research tests the hypothesis 
that bioreactor operating conditions, specifically fluid induced shear stress and 
oxygen tension, affect the extracellular matrix deposition in tissue engineered 
cartilage constructs.  This study identifies certain bioreactor conditions that 
increase the deposition of matrix components in the engineered constructs by 
means of bioprocessing conditions – both biochemical and physical, and 
correlating the extracellular matrix content of the tissue construct to its culture 
environment and mechanical strength.  This research addresses some 
fundamental issues that promote development of functional cartilage production 
in vitro.  
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Objective 1: Develop quantitative relationships between construct 
hydrodynamic loading, oxygen tension and material properties in a 
concentric cylinder bioreactor 
 
Matrix synthesis and deposition depends upon chondrocyte loading 
conditions.  In order to identify the effect of the hydrodynamic loading regimen 
and nutrient environment in the bioreactor, experiments were carried out under 
defined bioreactor conditions. The hydrodynamic loading was varied over the 
culture period and the kinetics of matrix production quantified.  Bioreactor 
experiments combining low oxygen tension and hydrodynamic loading were 
carried out to determine the effect of simultaneous stimuli on extracellular matrix 
synthesis.  The material properties of the constructs were measured to examine 
their load-bearing capability. 
Objective 2: Design and development of a perfusion bioreactor system for 
engineered cartilage constructs.  
 
Perfusion can be used to increase chondrocyte cell proliferation and 
matrix synthesis within the construct.  The concentric cylinder bioreactor 
configuration was modified to incorporate perfusion through the constructs. The 
new bioreactor design exposes cells within the construct to fluid flow, diminishes 
nutrient gradients, and provides hydrodynamic loading to stimulate chondrocytes 
to produce more extracellular matrix. The perfusion concentric cylinder bioreactor 
attempts to provide a uniform inter-construct environment with the ability to 
introduce intra-construct heterogeneity. 
This work identifies specific bioreactor operating conditions that increase 
both construct extracellular matrix content and desirable material properties.  In 
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addition, it has led to the development of a new bioreactor design that allows for 
a uniform inter-construct and non-uniform intra-construct hydrodynamic 
environment.  Thus, this work identifies specific culture conditions that are 
necessary for the development of cartilage constructs with enhanced material 






































Biochemistry of Cartilage 
Articular cartilage is a thin layer of soft connective tissue that overlies the 
articulating bony ends of diarthrodial joints.  It provides for the distribution of 
mechanical loading, resistance to compressive forces, and cushioning of the 
subchondral bone during joint movement (Kuettner et al., 1991).  The primary 
role of articular cartilage is to transmit mechanical stresses across the articulating 
joint.  The load bearing capability of cartilage is a result of the abundance of 
extracellular matrix (ECM) that the tissue contains.  The ECM in cartilage can be 
viewed as a complex biocomposite material that exhibits compressive stiffness, 
toughness, strength, resilience, and shock absorption.   
 Chondrocytes are the only cell type present in cartilage.  These cells are 
embedded in a complex extracellular matrix consisting of proteoglycans and 
collagen, with little to no cell-cell contact.  The proteoglycans make up to 5-10% 
of tissue wet weight, the majority of them being glycosaminoglycan (GAG) 
molecules.  A large fraction of cartilage is type II collagen, up to 10-30% of tissue 
wet weight.  Healthy cartilage is a highly hydrated tissue and has between 65-
80% water (Kuettner et al., 1991).  The extracellular matrix consists of many 
complex carbohydrates and proteins with a high electronegative charge that 
allows for binding large amounts of water. 
Chondrocytes synthesize, secrete and organize the extracellular matrix 
during different stages of development (Muir, 1995).  Chondrocytes are protected 
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from the potentially damaging forces of normal mechanical function by their 
surrounding ECM.  In vivo, the chondrocytes are constantly subject to changes in 
their hydrostatic environment that modulate their metabolic activities (Manicour et 
al., 1999).  Since cartilage is avascular, chondrocyte nutrition depends mainly on 
the diffusion of nutrients through the synovial fluid into the matrix.  The oxygen 
tension in cartilage can be as low as 1-3% and the cells are well adapted to 
these conditions (Brighton and Heppenstall, 1971).  Anaerobic glycolysis 
provides a large part of chondrocyte energy needs because of the hypoxic 
environment. 
The most abundant component of cartilage is collagen, mainly type II with 
collagen IX and XI being present in small quantities.  Collagen type II forms up to 
50% of the dry weight of the tissue (Eikenberry E.F and Bruckner, 1999).  
Collagen type II has a glycine rich amino acid sequence of glycine-X-Y where X 
and Y are hydroxyproline and proline arbitrarily.  The collagen network in 
cartilage provides tensional stability and mechanical strength.  This is achieved 
by collagen fibers linking to glycoproteins and proteoglycans.  These linking 
molecules also regulate fibrillogenesis by preventing accumulation of new 
collagen molecules to pre-existing fibrils.  By forming a fibrous network and 
interacting with proteoglycans and water, collagen serves to maintain the shape 
and form of the tissue under large forces.  Collagen types IX and XI also found in 
cartilage are fibril-forming collagens.  Type IX collagen has extensive cross-
linking capabilities while Type XI collagen forms a core on which type II collagen 
molecules are deposited (Manicour et al., 1999; Sandell and Aigner, 2001).   
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Non-collagenous proteins contribute to the regulation of tissue assembly 
and mechanical properties.  Aggrecan provides fixed charge groups, creating an 
osmotic environment in cartilage, immobilizing and restricting interstitial water 
flow.  The interaction between proteoglycans and collagen fibers provides 
cartilage with resistance to compressive and shear forces (Mow and Wang, 
1999; Muir, 1995; Stading and Langer, 1999).  Additional structure is provided by 
cartilage oligomeric matrix protein (COMP) (Di Cesare et al., 2002; Stading and 
Langer, 1999).  COMP is abundant near chondrocytes and may stabilize the 
collagen network, promote collagen fibril assembly, and regulate cell-matrix 
interactions.  The proteoglycan component in the extracellular matrix consists of 
a highly concentrated gel (up to 100 mg/ml) of proteoglycan immobilized in a 
dense network of collagen fibrils.  Chondroitin sulfate and keratan sulfate are the 
most abundant cartilage GAGs.  Keratan sulfate can account for between 5- 20% 
of total GAG in cartilage.  Hyaluronic acid is the only non-sulfated proteoglycan.  
Although it is present in small quantities in human cartilage (< 6% of total weight), 
it performs a very important biochemical function in the formation of proteoglycan 
aggregates.    Under normal physiological conditions, most proteoglycans exist 
as huge multi-molecular aggregates bound to hyaluronic acid and a link 
glycoprotein  (Hardingham et al., 1983; Plaas et al., 1983). 
Cartilage Ultrastructure 
  Cartilage is divided into three zones: superficial, transition and deep 
zone.  The cell morphology and collagen fiber orientation differs in each of these 
zones.  In the superficial zone, the collagen fibrils are oriented tangential to the 
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articular surface and are very closely packed (Figure 1).  The fibers in this region 
are typically 320 ± 50 Ǻ with a periodicity of 100 Ǻ.  The pericellular matrix has 
finer fibers about 120 Ǻ in diameter.  Collagen fibers in the transition zone have a 
periodicity of 640 Ǻ and their diameter varies from 300 to 600 Ǻ.  The diameter of 
fibers in the deep zone varies between 400 and 800 Ǻ and the periodicity is 640 
Ǻ.  In the middle and deep zones, collagen fibrils have a randomly oriented 
appearance with the fibers being very widely spaced (Zhu et al., 1993).   
Chondrocytes in the superficial zone are typically oval in shape, with the 
long axis of the cells oriented along the articular surface (Figure 2).  
Chondrocytes in the transition zone have a more rounded profile while the cells 
in the deep zone are arranged preferentially in a vertical direction relative to the 
articular surface (Hunziker et al., 2002).  Differences are found in the 
chondrocytes in terms of cell volume and surface area in the superficial zone and 
radial zone (Hunziker et al., 2002; Wong et al., 1996).  The cells in the radial 
zone have a much higher (~ 10 times more) biosynthetic activity as compared to 




Figure 1: Collagen fibril organization in native articular cartilage. The collagen 
fibrils are organized parallel to the articular surface in the surface zone, randomly 
in the middle zone and perpendicular to the calcified cartilage in the deep zone.  




Figure 2:  Histological image of chondrocyte organization through the full 
thickness of articular cartilage.  The chondrocytes are arranged parallel to the 
articulating surface and are arranged as perpendicular cascades near the 








Heterogeneity within the native tissue has been observed in the collagen 
fibril distribution and molecular weights of proteoglycan aggregates (Lonner, 
2004; Roy and Meachim, 1968; Mow et al., 1984).  Changes in cell shape in the 
zones are postulated to be an important mechanotransducer by which the 
biosynthetic activity of chondrocytes is regulated (Hunziker et al., 2002; Wong et 
al., 1996).   
Techniques using confocal microscopic stereology have been developed 
to give insight into the structural parameters of the tissue (Wong et al., 1996).    
These findings suggest that the chondrocytes harvested from different cell layers 
have different matrix synthesis rates.   
Cartilage Material Properties 
Cartilage loading can reach 20 MPa during normal activity.  Application of 
external load causes deformation, increases hydrostatic pressure and interstitial 
fluid flow (Davisson et al., 2002a) throughout the extracellular matrix.  The load is 
transmitted through the chondrocyte pericellular matrix and detected by cells 
through a variety of signaling pathways (Urban, 2000).  Native bovine cartilage 
has an aggregate modulus in the range of 0.47-0.89 MPa and dynamic shear 
modulus in the range of 0.2-2.5 MPa (Mow et al., 1984; Ratcliffe and Mow, 
1996).  The actual values depend on the location of the tissue specimen.  In 
addition to tissue location, the material properties also depend on tissue 
composition and ultrastructure.  The layered morphology of the collagen network 
and the orientation of the fibrils dictate the mechanical properties and the load 
bearing abilities of the tissue (Mow et al., 1984).   
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Zone specific analysis of adult native cartilage is important for 
understanding the structure-function relationship of native cartilage.  The material 
properties of cartilage are known to vary with tissue location and orientation.  
Permeability of native cartilage decreases with tissue depth; the decrease 
varying with distance from the articular surface.  Variable permeability is thought 
to provide a valuable mechanism for load distribution between the solid and fluid 
phases of cartilage.  Other studies propose that the anisotropy in the permeability 
of cartilage could be due to the GAG network geometry.  It has been suggested 
that the GAG network is not randomly oriented but there might be preferred GAG 
orientations and directionally dependent reduction of inter-GAG spacing (Quinn 
et al., 2001). 
 The biphasic model for cartilage shows that the cartilage exhibits 
significant anisotropy in its mechanical properties mainly due to the changes in 
the collagen fibril orientation in the different zones of the tissue (Poole et al., 
2001; Lonner, 2004).  The layered morphology of the collagen network 
(heterogeneity) and the orientation of the fibrils seem to dictate the mechanical 
properties and the load bearing abilities of the tissue (Lonner, 2004; Caplan and 
Goldberg, 1999).  The superficial zone provides the highest tensile properties 
found in cartilage; therefore it can accommodate forces due to compression, 
shear and tensile forces during articulation.  The middle and deep zone provide 
intermediate properties between those of the superficial zone and the calcified 
bone.    
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Osteoarthritis 
Osteoarthritis is one of the most common types of arthritis characterized 
by the degeneration of cartilage.  Degradation of cartilage in osteoarthritis is 
characterized by two phases: phase one, where the chondrocytes attempt to 
repair the damaged ECM with little success and phase two, where the activity of 
the enzymes produced by chondrocytes digests the ECM and matrix synthesis is 
inhibited.  In osteoathritic cartilage, chondrocytes continue to produce the matrix 
components; however they are unable to keep up with the rate of degradative 
catabolic activity and tissue degradation results.   
Studies indicate that enzymes such as collagenases and aggrecanases 
cause the degeneration of cartilage in osteoarthritis.  Collagenases (also known 
as matrix metalloproteinases) cause the degradation of the triple helix of collagen 
allowing for further degradation by aggrecanases.  Collagenases make an initial 
cleavage in a weak point in the collagen fibril and then the aggrecanases cleave 
the core protein (Mort and Billington, 2001),(Roughley, 2001).  Aggrecanases, in 
tandem with other enzymes cause the degradation of aggrecan.  These changes 
in the matrix components of cartilage cause it to weaken and therefore not be 
able to perform its biomechanical function. 
Articular cartilage exhibits very low capacity for self-repair because of its 
avascularity.  The repair tissue is a mixture of hyaline and fibro-cartilage and 
consists mainly of type I collagen as opposed to type II collagen.  Additionally, 
the repair tissue possesses inferior mechanical properties when compared to 
healthy tissue.  The change in composition and inferior biomechanical properties 
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of spontaneously formed repair cartilage contribute to the poor functionality of the 
repaired tissue  (Roughley, 2001; Altman et al., 1992). 
Diseased cartilage shows a distinctly different ultrastructure compared to 
healthy tissue.  Osteoarthritic cartilage shows vertical orientation of the collagen 
fibers throughout the thickness of the cartilage, right up to the superficial zone.  
The articulating surface is less smooth compared to healthy adult tissue.  The 
water content of the diseased tissue is higher, increasing the permeability and 
reducing the compressive modulus of cartilage (Roy and Meachim, 1968). 
Current treatment strategies available for cartilage regeneration include 
osteochondral grafting, autologous chondrocyte implantation, and mesenchymal 
stem cell regeneration.  Transplantation of autologous mesenchymal progenitor 
cells leads to filling of the defect with tissue that is less stiff and more compliant 
than the native tissue.  This suggests that the regenerated tissue may have 
inferior mechanical properties compared to healthy tissue.  Fresh osteochondral 
allografts have been transplanted in defect sites to study their potential for 
regeneration of functional cartilage (Lonner, 2004).  The success of this therapy 
is limited by the availability of graft tissue, viability of chondrocytes in the graft 
post-implantation, and careful patient and donor selection.  
Some of the surgical treatment methods are shaving of fibrillated articular 
cartilage and abrasion of the subchondral bone to allow for penetration of the 
subchondral plate and induction of chondrogenesis (Farnworth, 2000).  
Osteochondral shaving and subchondral abrasion of the articular cartilage are 
potential treatment therapies for large, full thickness defects (Kim et al., 1991).  
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However, these methods do not fully aid regeneration of new tissue or 
completely restore tissue function.  Electron micrographs of the repair sites show 
that no new superficial zone is formed and reconstruction of a smooth congruent 
surface is not possible by these methods.  The results from these studies are 
unpredictable, and are believed to be temporary.  Lack of long-term success with 
surgical therapies has motivated the development of tissue engineering of 
cartilage constructs in vitro for implantation.  
Tissue Engineering 
Tissue engineering of cartilage in vitro is a promising option for the 
production of implantable cartilage templates.  This area of biotechnology has 
been defined at the first scientific meeting devoted to tissue engineering in 1988 
at Lake Tahoe, California as “the application of the principles and methods of 
engineering and life sciences toward the fundamental understanding of structure-
function relationships in normal and pathological mammalian tissues and the 
development of biological substitutes to restore, maintain or improve function”.   
Some of the major challenges in tissue engineering include cell-sourcing, 
biomaterials for scaffold development, culture environment including bioreactor 
design and meeting patient demand. 
For in vitro studies chondrocytes have been harvested from cows (Martin 
et al., 2000), sheep (Neves et al., 2002), rabbits (Dunkelman et al., 1995) etc.  
Mesenchymal progenitor cells have been used to study their potential for 
differentiation into chondrocytes in vitro and production of cartilage constructs 
(Martin et al., 1998; Barry et al., 2001). More recently, human mesenchymal cells 
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have been used for the production of cartilaginous tissue in vitro (Neves et al., 
2002).  Biodegradable scaffolds seeded with chondrocytes and cultured in vitro 
allow the chondrocytes to proliferate and synthesize matrix.  These cell-seeded 
scaffolds allow for the development of tissue that is biochemically and 
morphologically similar to native tissue.  The seeding of chondrocytes on 
synthetic biodegradable matrices provides a large surface area for cell 
attachment and proliferation (Vacanti et al., 1991).   
Matrix scaffolds allow the chondrocytes to retain their differentiated 
phenotype and provide a three dimensional framework for tissue growth.  Ideally, 
the scaffold should possess a three dimensional structure that allows for high cell 
seeding densities, minimize diffusional constraints for nutrient transfer and 
degrade at a rate comparable to the rate of ECM synthesis (Freed et al., 1999).  
Polyglycolic acid (PGA) meshes support chondrogenesis from initial high cell 
densities (Freed et al., 1998).   
Biodegradable poly L-Lactic acid (PLLA), PGA and poly lactide-galactide 
(PLGA) copolymer meshes have been used in different studies for the in vitro 
growth of cartilage (Freed et al., 1993a; Freed et al., 1994c).   Polyphospazenes, 
polyanhydrides, polypropylene fumarate are some other biodegradable polymers 
that are being investigated for in vitro culture of chondrocytes (Behravesh et al., 
1999).  Studies on copolymers of PLLA and PGA have shown that the construct 
properties depend mainly on the composition of the scaffold.  The ratio of PLLA 
and PGA in the scaffold affects the chondrocyte adherence, proliferation and 
mechanical properties (Moran et al., 2003).  Increasing the amount of PLLA in 
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the scaffolds increases the compressive modulus and characteristic degradation 
time of the scaffolds.  However, the cell seeding efficiency and proliferation 
decreases with increase in the amount of PLLA.  The choice of the biomaterial is 
thus very important for the development of cartilage templates.  
Chondrocytes tend to retain their phenotype in vitro when cultured under 
conditions that resemble their natural environment.  The mechanical and 
biochemical signals that affect cartilage development in vivo are very likely to 
promote tissue growth in vitro.  Ideally the engineered tissue construct should be 
similar to native cartilage with respect to composition, matrix organization and 
mechanical properties.  A culture environment that incorporates the different 
factors that promote matrix component synthesis is essential for the production of 
functional cartilage constructs. 
Bioreactors in Cartilage Tissue Engineering 
The basic hypothesis for tissue engineering cartilage is that manipulating 
the physical and chemical environment of the cell seeded scaffold composite will 
modulate the structure and function of engineered cartilage (Freed et al., 1999).  
Bioreactors are useful tools to incorporate the appropriate physical and chemical 
environment for tissue engineered cartilage constructs.  Some of the main 
reasons why bioreactor culture enhances cartilage development in vitro are (a) 
enhanced nutrient and oxygen transport to the constructs is possible because of 
the mixing patterns, (b) spatially uniform cell seeding and nutrient delivery is 
possible because of bioreactor design, and (c) the hydrodynamic forces stimulate 
the chondrocytes toward increased matrix synthesis as compared to static 
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culture (Freed et al., 1993b; Ratcliffe and Niklason, 2002; Darling and 
Athanasiou, 2003) .  Some of the commonly used bioreactor configurations used 
are shown in Figures 3 and 4. 
Spinner flasks 
 
Spinner flasks are simple bioreactors that provide a turbulent fluid flow 
environment to alleviate nutrient and oxygen diffusion limitations.  Spinner flasks 
were one of the first bioreactor configurations used to grow tissue engineered 
constructs with cartilaginous composition and appearance.  These bioreactors 
are characterized by a high seeding efficiency and simple geometry.  Typically, 
scaffolds seeded with chondrocytes are attached to needles suspended from a 
stopper in the flask.  Media is added to cover the scaffolds and mixing is 
maintained with a magnetic stir bar in the bottom of the flask.  In order to alleviate 
diffusion limitations, the culture medium is continually stirred.  Stirring exposes 
the tissue to fresh nutrients and also shear forces.  Spinner flasks have their 
inherent drawbacks in terms of difficulty of scale-up and also individual handling.  
Also, the fluid flow is turbulent and not uniform throughout the bioreactor.  It is 
difficult to define the flow field around the construct and the constructs in the 
spinner flasks experience non-uniform shear gradients, mass transfer and 
nutrient gradients (Ratcliffe and Niklason, 2002).  The cartilage constructs 
cultured in spinner flasks have been characterized by the formation of a capsule 
on the outer edge of the construct (Ratcliffe and Niklason, 2002).  These 
constructs have an outer capsule with increased cell density and an inner core 
with fewer cells.  The constructs showed an increased release of GAG into the 
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media possibly due to the turbulent flow regime around the constructs.  The wet 
weight percentage of GAG was lower in spinner flask cultivated constructs as 
compared to the constructs cultured in other bioreactors.   
While spinner flasks have been successful as a bioreactor configuration 
for the development of cartilage constructs, certain limitations have been 
highlighted by these studies in bioreactor configuration.  These drawbacks 
highlight the bioprocessing needs for the culture of cartilage constructs and have 
led to the design and development of bioreactors that eliminate turbulent flow 




Figure 3: Different bioreactor configurations used in cartilage tissue engineering. 
(a) spinner flask, (b) rotating wall vessel bioreactors, (c) hollow fiber membrane 
bioreactors, (d) perfusion bioreactors, and (e) compression loading bioreactors. 






Rotating Wall Perfusion Vessel bioreactors (RWPV) 
 
The rotating wall perfusion vessel bioreactor has been used successfully 
in the culture of tissue engineered cartilage construct.  This bioreactor 
configuration has been used in long term studies for seven months to evaluate 
the material properties of the constructs.  The RWPV is typically designed to 
provide a suitable environment for shear-sensitive mammalian cells.  The RWPV, 
based on the viscous pump, has successfully cultured mammalian cells both on 
earth and in microgravity.  The constructs cultured in these bioreactors in 
terrestrial environments showed a more uniform appearance as compared to the 
constructs cultured in the spinner flasks.  The GAG and collagen wet weight 
fractions were relatively higher in these constructs as compared to constructs 
cultured in spinner flasks.  
The rotating bioreactor developed at NASA’s Johnson Space Center is 
configured as an annular space holding 110ml of culture medium and up to 12 
constructs.  The vessel is operated by solid body rotation in a horizontal plane.  
Vessel rotation can be adjusted so that the tissue constructs can be made to 
suspend in equilibrium between the acting forces or to rotate synchronously 
(Freed and Vunjak-Novakovic, 1997; Begley and Kleis, 2000; Begley and Kleis, 
2002).  The rotating wall bioreactor randomizes the effect of unit Earth gravity on 
freely suspended biological specimens and exposes them to dynamic 
fluctuations in fluid velocity, pressure and shear (Begley and Kleis, 2000; Begley 
and Kleis, 2002).  This allows the constructs to be in a state of perpetual free fall.  
The integration studies with native tissue showed clearly visible empty spaces 
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between the engineered and native tissue (Obradovic et al., 2001).  Also, long-
term growth studies (seven months) showed that the mechanical properties of 
the tissue remained subnormal as compared to native tissue. 
Perfusion Bioreactors 
 
Perfusion culture is a way of establishing nutrient supply throughout the 
thickness of the construct, overcoming the diffusion limitations.  In perfusion flow 
bioreactors, porous constructs are mounted in an impermeable housing, and fluid 
is forced through the construct.  Several constructs can be perfused while having 
one media reservoir.  A common design for perfusion bioreactors is usually to 
direct constant fluid flow through the developing tissue without stagnant or 
secondary flows. 
Although the complete mechanism is not well understood, perfusion is 
known to modulate many changes in the in vitro growth of chondrocytes including 
increases in matrix synthesis.  Perfusion increased the cellularity and matrix 
synthesis in the constructs as compared to static controls (Jin et al., 2001).  A 
bioreactor design developed by Advanced Tissue Sciences Inc. forced influent 
media through the cultured constructs as media flows from the bottom to the top 
of the bioreactor vessel (Davisson et al., 2002b).  Ample gas exchange and 
equal fluid flow distribution were demonstrated during the operational and sterility 
testing phases of the bioreactor.  The axial flow through the sample induced in 
the bioreactor produced multiple focal areas of columnar cell orientation and 
assembly (Davisson et al., 2002b).  The ultrastructure of constructs cultured 
under perfusion culture with intermittent fluid pressure showed the orientation of 
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collagen fibers around the chondrocytes with proteoglycan aggregates 
intertwined about collagen fibrils (Carver and Heath, 1999b; Carver and Heath, 
1999a).  The compressive modulus of the constructs cultured in the perfusion 
environment was higher compared to the constructs cultured in spinner flasks 
alone.  
Concentric cylinder bioreactor (CCBR) 
 
The main goal of this bioreactor is to provide a reduced shear stress 
environment for the efficient dynamic cell seeding in the constructs while causing 
minimal damage to cells (Saini, 2002; Saini and Wick, 2003).  This bioreactor has 
a large surface area for construct growth and high productivity.  Bioreactor 
design objectives include a low shear stress regime to minimize cell damage and 
allow for efficient dynamic seeding, a large growth area to increase construct 
production per unit reactor volume, and a simple geometry to allow for calculation 
of nutrient transport and hydrodynamic loading on the constructs (Figure 4).  
The concentric cylinder bioreactor is based on a concentric cylinder 
viscometer design for cell culture (Saini, 2002; Saini and Wick, 2003). The 
bioreactor environment is homogeneous for tissue production because of the 
hydrodynamic and mass transport conditions provided by virtue of its design.  
The concentric cylinder bioreactor provides a homogenous, controllable flow 
environment across the construct.  It has an easily scalable design and use of 
increased number of constructs does not greatly affect the flow field (Williams et 
al., 2002).  
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Ri = 4.78 cm




















Figure 4: Concentric cylinder bioreactor.  This bioreactor was designed in our lab 
by Dr. Sunil Saini and is based on the design of the concentric cylinder 
viscometer.  The bioreactor consists of a stationary inner bob and a rotating outer 








Production of ECM in the concentric cylinder bioreactor varies with the 
outer cup rotation.  Specifically, studies in a concentric cylinder bioreactor have 
shown that higher shear promotes glycosaminoglycan (GAG) synthesis early in 
culture (at 12 days), but the GAG synthesis drops at later time points with higher 
outer cup rotation rate.  In contrast, lower shear prolongs the period of matrix 
GAG deposition up to 28 days (Saini and Wick, 2003).  With low outer cup 
rotation rate, chondrocytes synthesized higher GAG at later time points of 2-4 
weeks (Saini, 2002).  These studies indicate that steady shear over the culture 
period alone may not be sufficient to increase extracellular matrix in cartilage 
constructs.  This suggests that varying the outer cup rotation rate over the culture 
period in the bioreactor will lead to sustained production of matrix.  Thus, 
chondrocytes exhibit a differential response to hydrodynamic loading, suggesting 
that chondrocyte matrix deposition kinetics can be regulated by modulating the 
shear stress in a controlled manner over the culture period. 
Bioprocessing Conditions 
 Specific bioprocessing conditions have been shown to increase construct 
extracellular matrix deposition and induce a favorable environment for 
chondrogenesis in bioreactor culture.  These conditions include low oxygen 
tension (hypoxia), fluid induced shear stress, mechanical loading, and growth 
factors.  Some of these conditions that have a direct bearing on the current 
research on our work are reviewed here. 
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Low oxygen tension 
 
Articular cartilage experiences low oxygen tension in vivo and the cells 
carry out their metabolic activity anaerobically (Brighton and Heppenstall, 1971).  
Proteoglycan aggregation was found to be higher at low oxygen tensions of 3% 
in chondrocytes cultured in vitro compared to culture in 21% oxygen tension 
(Clark et al., 1991).  Under physiologic conditions, cartilage exists under low 
oxygen tension conditions, sometimes with oxygen tension as low as < 1%.  In 
vitro, studies show that low oxygen tension has a beneficial effect on 
chondrocyte proliferation and matrix deposition.  Bovine cartilage explants 
cultured under oxygen tension of 6% showed the same level of GAG synthesis 
as in fresh tissue, when cultured over 7 days with 20% fetal calf serum (Ysart 
and Mason, 1994).  Chondrocytes cultured in monolayers showed an increase in 
matrix synthesis in the first two weeks of culture followed by no net increase in 
matrix production in a 20 day culture at 1% oxygen tension (Murphy and 
Sambanis, 2001b).  A low oxygen tension of 5% also helps to restore the key 
phenotypic markers of passaged chondrocytes in alginate cultures (Murphy and 
Sambanis, 2001a).  Thus low oxygen tension is an important parameter for 
bioprocessing conditions for in vitro chondrogenesis and cartilage construct 
development.  
ATP is the universal energy currency in all cells and its formation is 
coupled to the oxidation of carbon rich energy sources.  Glycolysis is the energy 
conversion pathway in many cells.  Glycolysis is the pathway used to convert one 
molecule of glucose to two molecules of pyruvate.  In anaerobic conditions, or in 
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aerobic organisms undergoing very high rates of glycolysis, the pyruvate is 
converted to lactate.  The pH falls when large quantities of lactate are produced.  
Chondrocytes undergo a combination of aerobic and anaerobic metabolic 
pathways.  During hypoxia, the cells shift to a primarily glycolytic mode for their 
energy needs.  Thus, when chondrocytes are cultured in low oxygen tension, 
lactate production increases in monolayer culture.  Dynamic changes in the 
oxygen tension environment constitute a potential signaling mechanism for the 
regulation of the expression and activation of redox signaling molecules and 
inflammatory cytokines (Vittur et al., 1994; Kuettner et al., 1989).   
Biochemical changes associated with low oxygen tension in chondrocytes 
are poorly understood and the reports on the effect of low oxygen tension on 
chondrocytes are contradictory.  Imposition of a hypoxic environment on cultured 
chondrocytes causes an increase in glucose consumption and lactate synthesis.  
Low oxygen tension plays an important role in regulating ECM synthesis in 
cartilage tissue engineering.  However, the mechanisms of action of hypoxia are 
not clearly known in three dimensional chondrocyte cultures.   
The variation in oxygen tension regulates the functioning of transcription 
factors like hypoxia inducible factor -1α (HIF-1α) (Cramer et al., 2004; Coimbra et 
al., 2004).  HIF-1 is a transcription factor that binds specifically in hypoxia to a 
hypoxia response element in the promoter or enhancer region of the various 
hypoxia inducible genes.  These genes include erythropoietin (EPO), vascular 
endothelial growth factor, glucose transporters and glycolytic enzymes.  HIF-1α 
null chondrocytes were unable to maintain ATP levels in hypoxic 
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microenvironments, indicating that this factor is essential for the regulation of 
chondrocyte metabolism.  HIF-1α also affects the extracellular matrix synthesis 
by chondrocytes.  The synthesis of type II collagen is decreased under low 
oxygen conditions by chondrocytes lacking HIF-1α (Cramer et al., 2004).  
Therefore, it maybe possible that in vitro, HIF-1α may play an important role in 
chondrocyte metabolism. 
Mechanical loading and fluid induced shear stress 
 
Chondrocytes exhibit a distinct sensitivity to static and compressive 
loading.  This response to loading is observed in both explants and in vitro 
engineered tissue and therefore is relevant to engineered cartilage (Torzilli et al., 
1997).  Mechanical loading alters cartilage metabolism.  Physical forces such as 
compression, fluid flow, and hydrostatic flow have been implicated in the 
regulation of matrix metabolism in articular cartilage in vivo, as well as in 
cartilage explants and tissue engineered cartilage constructs (Freed et al., 
1994b; Jin et al., 2001).  Studies have been conducted to compare static vs. 
dynamic compression on cartilage explants (Davisson et al., 2002a; Wu et al., 
1999).  Dynamic compression increases the amount of matrix produced in 
cartilage constructs in vitro whereas static compression decreases the matrix 
content (Davisson et al., 2002a).  Dynamic compression also stimulates 
production of matrix in cartilage explants.  For engineered tissue, static 
compression decreases chondrocyte metabolism (Jin et al., 2001).   Based on 
these results, the response of chondrocytes seems to be favored towards a 
dynamic loading regimen. 
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The functionality of the cartilage construct depends mainly on its 
mechanical properties.  Correlation of fluid flow through and around the construct 
with matrix synthesis and matrix loss during dynamic compression protocols 
suggests that fluid flow is an important stimulatory signal.  Fluid flow modulates 
cellular alignment and shape.  Also, fluid flow through the construct increases the 
synthesis and accumulation of sulfated GAGs and collagens leading to improved 
compressive properties of the constructs.  Fluid flow direction may play an as yet 
unidentified role in the fibrillar arrangement of collagen type II and proteoglycan 
fibers.  The kinetics of matrix production and cellular proliferation is also affected 
by culture during fluid flow.  These effects may be modulated by the intracellular 
calcium signaling and such changes are associated with cellular proliferation and 
matrix synthesis.  Thus, there is a need for a well-defined fluid flow regime in 
both the radial and axial directions within the construct to promote matrix 
synthesis and deposition.  Intermittent compression or shear increases 
production of ECM and the construct cultured under such conditions was  
significantly thicker compared to unstimulated controls (Davisson et al., 2002a).   
These data indicate that the use of varying shear stress over the culture 
period as opposed to steady shear is a potentially powerful way to stimulate 
chondrocytes and enhance extracellular matrix deposition.  
Growth factors 
 
Growth factors like the transforming growth factor (TGF-β), insulin like 
growth factor (IGF), and bone morphogenetic proteins are some of the growth 
factors that have been used in cartilage tissue engineering to promote 
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differentiation, proliferation and extracellular matrix deposition.  TGF-β1 has been 
used in chondrogeneic differentiation from mesenchymal progenitor cells (Barry 
et al., 2001; Fukumoto et al., 2003).  In vitro, studies on cartilage explants and 
engineered tissue on the effect of TGF-β show that this growth factor increases 
the rate of proteoglycan synthesis.  Also, TGF-β is capable of redifferentiating 
phenotypically altered chondrocytes in osteoarthritic cartilage (Grimaud et al., 
2002).  TGF- β1 used at a concentration of 30 ng/ml increased construct collagen 
content by 15% over 4 weeks in a spinner flask bioreactor configuration (Blunk et 
al., 2002).  IGF-1 independently and in combination with mechanical loading 
increased construct extracellular matrix deposition in tissue engineered cartilage 
constructs (Gooch et al., 2001a).  Bone morphogenetic proteins 2, 12, and 13 
used in the concentration range of 1-100 ng/ml increased both GAG and collagen 
deposition in cartilage constructs (Blunk et al., 2002).  The combination of IGF-1 
(50 ng/ml) and TGF- β1 (30 ng/ml) increased construct GAG and collagen 
content by 63% and 67% respectively as compared to controls (Blunk et al., 
2002).  Thus, growth factors by themselves and in combination with mechanical 
loading can be powerful regulators of chondrocyte proliferation and extracellular 
matrix deposition in tissue engineering. 
Thus, bioreactors can be effectively used to impart the various mechanical 
and biochemical forces required to grow implantable cartilage constructs.  One of 
the issues that needs to be addressed is fundamental studies that help identify 
combinations of cells, scaffolds, nutrient and hydrodynamic loading conditions 
that will lead to tissue suitable for implantation.  Current technology focuses 
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primarily on growing one or a small number of constructs under conditions that 
are not well defined.  Under these circumstances it is difficult to quantitatively 
relate the bioreactor operating conditions to construct ultrastructure and material 
properties.  Bioreactors such as the spinner flask and rotating wall vessel 
bioreactors do not provide a uniform flow environment for tissue growth. These 
bioreactors also exhibit poor fluid volume utilization and produce heterogeneous 
tissue constructs.  The concentric cylinder bioreactor for the growth of cartilage 
constructs provides a uniform hydrodynamic and nutrient environment for the 
constructs (Saini, 2002; Williams et al., 2002).   There is a need to identify 
specific conditions that enhance extracellular matrix deposition in the construct. 
Little quantitative data exist to predict how bioreactor conditions will 
enhance tissue development.  The complex mechanical environment cartilage 
experiences in vivo dictates the metabolic events within the tissue and has 
prompted much work in defining how mechanical factors stimulate chondrocyte 
cell function in vitro.  Although mechanical and biochemical stimulation enhances 
ECM synthesis in bioreactors, the rate of matrix deposition decreases with time 
(Saini and Wick, 2003; Gooch et al., 2001b) leading to constructs with inferior 
mechanical properties. 
Motivation for Current Research 
Based on these observations, the current research seeks to identify the 
effect of specific bioprocessing conditions on construct extracellular matrix 
content and material properties.  Because multiple factors affect cartilage tissue 
engineering, this work focuses on two primary chondrocyte modulators - fluid-
 34
induced shear stress and low oxygen tension.  Specifically, the effect of varying 
hydrodynamic loading is studied under two loading schedules – increasing 
hydrodynamic loading and decreasing hydrodynamic loading.  These loading 
schedules are detailed in Table 1.  The combination of decreasing hydrodynamic 
loading with low oxygen tension (5%) and TGF-β1 is explored.  These studies 
are carried out in the concentric cylinder bioreactor.  In order to incorporate 
multiple fluid flow regimes through the construct, the perfusion concentric 
cylinder bioreactor is designed.  This bioreactor allows for shear stress on 
construct surface and perfusion flow through the construct.  Short term and initial 
long term construct studies have been carried out in this bioreactor to study the 
effects of multiple fluid flow regimes.   
A challenge for cartilage tissue engineering is increasing mechanical 
strength of the constructs.  While the composition (chondrocytes, proteoglycan 
and collagen) of cartilage constructs from bioreactors is similar to native cartilage 
(Kuettner et al., 1991), tissue-engineered cartilage grown in bioreactors is 
relatively weak, with mechanical properties approximately ~10-25% of native 
cartilage (Vunjak-Novakovic et al., 1999; Freed et al., 1997; Martin et al., 2000; 
Noel et al., 2002; Vunjak-Novakovic et al., 2002), except when bioreactor culture 
time is 7 months (Martin et al., 2000).  Since greater matrix accumulation 
enhances construct mechanical properties (Martin et al., 2000), a quantitative 
understanding of how bioreactor environment promotes cartilage development is 
important.  In this work, systematic manipulation of select hydrodynamic and 
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nutrient environments in order to increase construct mechanical properties has 
been addressed.  
 
Table 1: Hydrodynamic loading regimens studied in the concentric cylinder 
bioreactor 
Loading regimen 0-12 days 13-24 days 25-35 days
Decreasing hydrodynamic loading 76 rpm 38 rpm 19 rpm 




MATERIALS AND METHODS 
 
All chemicals are obtained from Sigma Chemical Company (St. Louis, 
MO) and tissue culture supplies from VWR.  Fetal bovine serum was obtained 
from Atlanta Biologicals Ltd (GA). 
Tissue Digestion And Cell Isolation 
Knee joints from freshly slaughtered male calves 2-4 weeks old were 
obtained from either Lampire Biologicals (Pipersville, PA) or from Research 87 
(Marlborough, MA) within 24 hours of slaughter.  The joints were shipped on ice 
overnight to the Georgia Institute of Technology.  Fresh articular cartilage from 
the femoral-patellar grooves was obtained under aseptic conditions as described 
earlier (Freed et al., 1993a; Freed et al., 1994a).  The joint was cleaned, and the 
exposed cartilage was washed in sterile phosphate buffered saline with EDTA 
(3.72 g/L) (PBE).  Articular cartilage from the femoral patellar groove and femoral 
condyle was dissected using a sterile surgical scalpel.  The pieces of tissue were 
collected in sterile petri-dishes containing PBE.  The PBE was replaced with 
complete chondrocyte culture medium and the tissue was chopped into pieces of 
approximately 1 mm3.  Complete chondrocyte culture medium consisted of 
Dulbeco’s Modified Eagle Medium (DMEM), containing glucose (4.5 mg/L) and 
glutamine (584 mg/L), 10% fetal bovine serum (FBS), ascorbic acid (100 µg/ml), 
non-essential amino acids (0.1mM), L-proline (0.4mM), 1% penicillin-
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streptomycin, sodium bicarbonate (3.72g/L), 1% antimycotic-antibiotic, HEPES 
buffer (10 mM).   
The tissue chunks were digested in collagenase type II (Worthington 
Biochemicals, PA) (activity 300U/mg) in DMEM (1.5 mg/ml) overnight in an 
incubator at 37°C and 5% CO2.  The resulting cell suspension was centrifuged in 
a centrifuge at 70g for 12 minutes.  The supernatant solution was aspirated and 
sterile PBE was added to the 50 ml centrifuge tubes to wash the cells and 
remove residual collagenase.  The cells were centrifuged three times for 12 
minutes each with fresh changes of PBE for every wash. This was done to 
ensure that the cell viability was not harmed by long term exposure to 
collagenase.  The cells were then suspended in 50 ml of complete DMEM and 
the cell pellet was broken by repeated pipeting using a 5 ml pipet.  After a 
uniform cell suspension was obtained, 100 µl of this cell suspension was taken in 
a 1.5 ml Eppendorf tube along with  400 µl of medium and 100 µl of Trypan Blue 
was added.  The cell number was obtained by using a hemacytometer using 
Trypan Blue exclusion method.  Typical yield of chondrocytes was about 60 
million cells per gm wet weight of native tissue.  
Scaffold preparation and sterilization 
Poly-L-Lactic acid crystals with a weight averaged molecular weight of 
100,000 were obtained from Polysciences Inc (Warrington, PA).  Scaffolds were 
prepared by porogen leaching using sodium chloride crystals as previously 
described (Saini and Wick, 2003; Mikos et al., 1994).  PLLA crystals (0.5 gm) 
were dissolved in 5-7 ml methylene chloride (Fisher Scientific, Pittsburgh, PA).  
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The crystals were allowed to dissolve completely in methylene chloride and this 
took about 20-30 minutes.  Sodium chloride (4.5 gm) with crystal diameter 106-
150 µm was poured into a 50 mm Teflon dish and the polymer solution was 
added to it and mixed well.  The polymer casts were allowed to set for about 48 
hours.  The cast polymer was then placed in a beaker with deionized (dI) water 
and sodium chloride was leached out into solution.  The salt leaching was done 
for about 48 hours with multiple changes of deionized water.  The scaffolds were 
punched into 10 mm diameter disks using a biopsy punch.   The polymer 
scaffolds were allowed to dry and mounted onto thin plastic shims using a very 
small amount of inert silicone adhesive.  Scaffolds were sterilized by three 
washes for 15 minutes each in 70% ethanol and three washes with sterile 
deionized water.  After this treatment, the scaffolds were treated as sterile. Just 
prior to mounting the scaffolds on the bioreactor, they were exposed to ultraviolet 
light for 30 minutes.  For all bioreactor studies, scaffolds were 1 cm in diameter, ~ 
2 mm thick and 90% porous.   
Concentric cylinder bioreactor 
The concentric cylinder bioreactor was designed in our lab by Dr. Sunil 
Saini, a former graduate student at Georgia Institute of Technology (Saini, 2002; 
Saini and Wick, 2003; Saini and Wick, 2004; Williams et al., 2002).  This 
bioreactor was used to perform the studies comparing the effects of different 
loading regimens and low oxygen tension on cartilage construct development.  
The bioreactor design is described in detail in the background. 
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Construct growth studies 
Different conditions were examined in the concentric cylinder bioreactor to 
study at the effect of hydrodynamic loading caused by fluid-induced shear stress, 
and the effect of combining low oxygen tension at 5% with hydrodynamic loading. 






Table 2: List of Experiments 
 








Low  oxygen tension 
at steady shear 
Rotation 38 rpm 
20% vs. 38 rpm 5% 
O2 
35 days 2 12, 24, 35 2 
Decreasing 
hydrodynamic loading 
Steady shear at 76 
rpm vs. 
DHL at 76, 38, 19 
rpm 
35 days 2 12, 24, 35 4 
Increasing 
hydrodynamic loading 
Steady shear at 19 
rpm vs. IHL at 19, 38, 
76 rpm 
35 days 2 12, 24, 35 3 
Decreasing 
hydrodynamic loading 
with low oxygen 
tension 
DHL and 20% O2  vs. 
DHL and 5% O2 
35 days 2 12, 24, 35 4 
Effect of TGF-β1 No TGF-β1 vs 0.2 
ng/ml TGF-β1 
24 days 2 12, 24 1 
Effect of TGF- β1 + 
DHL 
DHL vs DHL + TGF- 
β1 0.2 ng/ml 
35 days 2 12, 24, 35 4 
Perfusion bioreactor 
seeding study 
150 X 106 cells for 16 
constructs 
4 days 1 2, 3, 4 4 
Short term construct 
development 
Perfusion from day 4 
to day 14 (10 ml/min) 
14 days 1 4, 7, 11, 14 4 
Long term construct 
development 
Perfusion from day 4 
to day 35 (10 ml/min) 





Perfusion Concentric Cylinder Bioreactor 
 The primary goal of the perfusion shear flow bioreactor is to incorporate 
two flows through the construct.  The objective of doing this is to induce cell 
alignment through the thickness of the tissue and obtain cartilage with 
architecture similar to that of native cartilage. 
Design and development 
The perfusion concentric bioreactor incorporates homogenous fluid flow 
environment external to the construct with fluid perfusion through the construct 
(Figure 1).  This bioreactor incorporates media flow through porous constructs to 
increase contact of the media with the scaffold and expose the interior of the 
construct to flow for better cell seeding and matrix deposition.  This bioreactor is 
also capable of promoting cell alignment within the construct and can be used to 
induce anisotropy in the engineered tissue similar to native tissue.  The perfusion 
concentric bioreactor consists of an outer polypropylene cup and an inner central 
tube designed to perfuse constructs.   The outer cup is held on a polypropylene 
base which is connected to a motor. This is the same as in the concentric 
cylinder bioreactor (Figure 4).  Figure 5 shows the inner tube with the construct 
housing.    
The entire inner perfusion tube is made of polycarbonate to facilitate visual 
observation of the fluid flow.   The inner tube is attached to an aluminum support 
bar with provisions to allow a fluid flow circuit from the media reservoir to the 
inner tube.   Fluid is pumped in through the inner tube by means of a roller pump.   
A loose fitting Teflon cap is provided to cover the glass cup to prevent possible 
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contamination.  A working prototype perfusion concentric bioreactor has been 
built with 2 rows of construct holders (Figure 5).  The simple scalable geometry 
allows for easy incorporation of more construct holders on the central tube for 
scale-up purposes.   An overflow reservoir collects the media in the cup and 
provides for media circulation through the construct.   This overflow is designed 
to maintain the fluid level in the glass cup and allows for constant replenishment 
of fresh media.   Media is pumped in through the constructs at a controlled rate to 
facilitate construct seeding and tissue growth. 
The construct holder (Figure 6) is designed so that most of the construct 
surface is exposed to fluid flow.  Tissue constructs must be fixed in space to 
have controlled mechanical stimulation but fluid flow through the constructs must 
not be constrained.   The design of the construct holder is such that it allows for 
construct development with minimal contact of the polymer scaffold to any other 
surface.   
 The construct holder built for the prototype has an outer diameter of 1.25 
cm and inner diameter of 1 cm.   The constructs used in the preliminary studies 
are 1cm in diameter and 2 mm thick.   The mouth of the construct holder has a 
gradual narrow to wide progression in terms of inner diameter.  Very small nylon 
set screws are positioned at the end of the holder.  The set screws restrain the 
constructs from flowing out into the outer cup without causing physical damage to 
the constructs.   The narrow inner diameter of the construct holder tube and the 
set screws essentially hold the constructs in place with minimal contact on the 
faces of the scaffold.   This way, most of the construct surface area is available 
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for perfusion flow, cell seeding and matrix deposition.  Culture medium is 
constantly pumped through the central tube which plays the role of a hub for all 
the construct holders.   As the medium level rises, the fluid is continuously 
pumped out from the overflow reservoir.    A photograph of the inner tube from 















Figure 5: Schematic of the perfusion concentric cylinder bioreactor. Shown here 
is the outer cup and the inner perfusion tube with construct holders. 
 
 





Fluid flow through the 
construct 











Figure 7: Photograph of the prototype inner tube built for the perfusion shear flow 
bioreactor.  The inner tube, construct holder, overflow reservoir and set screws 







Set screws to retain the 
constructs in place 
Inner Tube 
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The gap between the outer glass cup and the inner cylinder is increased 
to 10mm in this bioreactor configuration.  Previous studies show that maintaining 
a 3 mm gap between the inner bob and the outer glass cup in the concentric 
cylinder bioreactor did not cause any oxygen deficiency in the constructs during 
the growth period.  The perfusion system design also allows for increased 
oxygen dissolution in the media.  Thus, this system continues to provide required 
oxygen supply to the constructs.  
The constant surface shear in the concentric cylinder bioreactor is 
because of the uniform gap width between the concentric cylinder.  The gap 
width is not uniform in the perfusion design.  However, because of the outer cup 
rotation, the construct surface experiences shear stress.  It is assumed that the 
all the constructs experience surface shear stress in the same range because 
they are located at the same distance from the outer cup. 
The perfusion system has a high potential for scale up because of its 
inherent design.   The ability of the cup to contain a large volume of media and 
the length of the central tube allow for easy scalability of the bioreactor.   The 
number of construct holders can be increased along the length of the inner tube 
to facilitate increase in the volumetric productivity.   Availability of nutrients is not 
a limiting concern because the fluid volume is large in the bioreactor and 
perfusion increases nutrient supply to the interior of the constructs.   Increasing 
the capacity of the bioreactor only requires linear scale-up and not a series of 
complex calculations. 
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 Perfusion flow, shear stress, hydrodynamic loading, increased oxygen 
supply and a large scale-up potential make this device capable of incorporating 
the necessary physical factors required for chondrocyte proliferation, matrix 
deposition and tissue maturation.   Previous studies have shown that each of the 
aforementioned factors when individually applied showed a positive effect on 
chondrogenesis and matrix production.  The perfusion concentric cylinder 
bioreactor allows for simultaneous application of these physical parameters for 
the optimal tissue engineering of cartilage constructs.   
Construct growth studies in the perfusion bioreactor were carried out to 
evaluate cell seeding efficiency, cell viability in the bioreactor environment, short 
term construct development and preliminary long term construct development. 
These studies are outlined in Table 2 
Bioreactor Set-up 
Two days prior to start of the experiment, the bioreactor outer cup and 
inner bob or tube were treated with Sigmacote® to form a thin, inert silicone 
coating on the bioreactor components to prevent cell adhesion.  The Sigmacote ® 
solution was allowed to evaporate overnight.  The bioreactor components were 
then washed with soap and water and allowed to air dry prior to steam 
sterilization in an autoclave.  Steam sterilization was carried out at 121°C and 15 
psig for 20 minutes.  After sterilization, the bioreactor parts were assembled 
aseptically in the laminar flow hood.   
For all construct growth studies in the concentric cylinder bioreactor, 16 
scaffolds were used. These scaffolds were attached to the inner bob in a regular 
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staggered array pattern in two rows. The constructs were pasted on a thin plastic 
shim and mounted to the inner bob by means of inert silicone adhesive.  In the 
perfusion bioreactor, the sterile scaffolds were placed in the construct holders 
and the set screws used to restrain the constructs in place were tightened using 
sterile forceps.   
Bioreactor Seeding and Feeding 
Concentric Cylinder Bioreactor 
The bioreactor mount was cleaned and sprayed with 70% ethanol and 
then placed in a 37°C, 5% CO2 incubator.  After the chondrocyte cell suspension 
was prepared and the cell concentration was determined, the volume of cell 
suspension containing 100 X 106 cells was added to the bioreactor cup. Then 
complete DMEM was added to bring up the total volume to 62 ml. The solution 
was made uniform by a series of pipetting steps using a 5 ml pipette. The inner 
bob was lowered carefully into the cup.  The bioreactor was then placed on the 
rotating base in the incubator.  The inner bob was stabilized by fastening it on to 
the support arms with set screws.  These steps were repeated for each 
bioreactor.  The motor speed controller was fit with a timer device that allowed for 
automated change of direction of rotation every 12 hours.   
 After 48 hours, 31 ml of the culture medium was replaced.  After 4 days 
from seeding, the entire 62 ml of medium was replaced.  From then on, the 
bioreactor was fed every 48 hours with 31 ml media change.  To replenish 
culture medium, the bioreactor was moved to the laminar flow hood.  The inner 
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bob was removed carefully and placed in a sterile 150 mm petri dish.  The 
designated amount of cell culture medium was removed from the bioreactor cup, 
and 1 ml was saved in a labeled Eppendorf tube for further analysis.  The 
required amount of fresh DMEM at 37°C was added to the cup and the inner bob 
was lowered into the cup. 
Perfusion Bioreactor 
For the perfusion bioreactor, the seeding was done as 150 X 106 cells per 
bioreactor because of the increased volume in the bioreactor. One hundred and 
fifty million cells were added to 500 ml of culture medium in the outer cup.  
Because of the hollow inner tube and the increased gap between the outer cup 
and the inner tube, the volume of culture medium added to the perfusion 
bioreactor was large.  At least 400 ml of culture medium was required to 
submerge the two rows of constructs.  After addition of culture medium, the inner 
tube was slid into the outer cup. The seeding phase for the perfusion bioreactor 
was carried out for 4 days without perfusion.  Perfusing the cell suspension 
through a roller pump would cause the death of most of the cells. Therefore, 
seeding was carried out through outer cup rotation maintained at 38 rpm in all 
studies.  After 4 days of seeding, the complete medium in the cup was changed 
and replaced with fresh medium.  Fresh medium was added to the reservoir.  
Perfusion was carried out at 10 ml/min and recirculated.  For the 14 day 
experiments, the medium was replaced on days 4, 7 and 11 after initiation of the 
experiment.  For the 35 day experiment, the bioreactor was fed at 3-4 day 
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intervals.  All the components were treated with Sigmacote® to prevent cell 
adhesion to any bioreactor surface.   
Once cell seeding was completed, the remaining cell suspension was 
drawn out of the bioreactor to check for cell seeding efficiency and to remove the 
dead and/or unattached cells.   The cup was refilled with enough culture medium 
to submerge the constructs and then fluid was pumped through the inner tube.   
To complete the loop, fluid was continually pumped out of the overflow thereby 
removing the excess culture medium.  The medium in the reservoir was changed 
periodically.   Constructs were harvested at different time points for biochemical 
analyses. 
Construct Harvest 
Construct harvest schedule depended on the experiment design (Table 2).  
All constructs harvested were washed in PBE to rid them of serum components 
and stored in Eppendorf tubes at -20°C until further analysis. Thirty five day 
samples were used for mechanical testing.  These samples were washed in PBE 
and then frozen at -20°C, in PBE containing 1X protease inhibitor cocktail.  The 
cocktail would prevent any degradation of extracellular matrix components while 
in storage.  
Construct Analysis 
 For biochemical analysis, the entire construct was digested in papain and 




Harvested constructs were frozen, dried in a vacufuge and digested in 
papain enzyme solution.  The papain solution was prepared by dissolving 500 µl 
of papain solution in 100 ml of PBE at an activity of 35 U/mg of papain 
(Worthington Biochemical Corporation, Lakewood, NJ).  1 ml of this solution was 
added to each construct.  The Eppendorf tube was then placed in a high 
temperature water bath at 56°C and the entire construct was digested overnight.  
The digested samples were stored at -20°C until further analysis.  
Construct DNA Determination 
The DNA content in the constructs was determined using a fluorescent 
dye.  The quantitative Picogreen DNA determination kit was obtained from 
Molecular Probes (Eugene, OR).  The kit was used in accordance with the 
accompanying procedure.  The dilution buffer provided with the kit was a 20 X TE 
buffer (10 mM Tris-HCl, 1mM EDTA, pH 7.5).  This buffer was diluted to 1X.  Calf 
thymus DNA standard at 100 µg/ml was provided. Dilutions of the standard were 
made to obtain final concentrations as shown in Table 3. The Picogreen reagent 
was prepared by adding 0.1 ml of Picogreen dye to 19.9 ml of 1X TE buffer. The 
samples usually had to be diluted in the ratio 1:20 to minimize noise in the assay 
and obtain accurate measurements.  The assay was carried out in a 96 well 
black microplate. 100 µl of sample was added to the well and 100 µl of freshly 
prepared dye was added. The plate was covered in aluminum foil and incubated 
at room temperature for 2-5 minutes.  The plate was read in a fluorescence plate 
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reader at excitation of 480 nm and emission of 520 nm. The resulting amount of 
DNA was calculated by interpolating on the standard curve.  The cell number 






















Table 3: DNA standards for Picogreen assay 
Volume (µl) 
of 2 µg/ml 
DNA stock 
Volume (µl) 







0 100 100 0 
0.1 99.9 100 1 
1 99 100 10 
10 90 100 100 
30 70 100 300 
50 50 100 500 
80 20 100 800 




Table 4: GAG assay standards 
Chondroitin Sulfate  Working Solution  DI water 
           1 µg       100 µl    900 µl 
           2 µg       200 µl                800 µl 
           3 µg        300 µl    700 µl 
           4 µg       400 µl    600 µl 
           5 µg       500 µl    500 µl 
           6 µg       600 µl    400 µl 
           7 µg       700 µl    300 µl 
           8 µg       800 µl    200 µl 
           9 µg       900 µl    100 µl 









Construct GAG determination 
The amount of  sulfated GAG present in the constructs was determined by 
the method of Farndale (Farndale et al., 1982).  Chondroitin sulfate (CS) 
standards were prepared by dissolving bovine CS in PBE to obtain a stock 
solution of 50 mg/ml. A working solution of 100 µg/ml was prepared by diluting 
the stock solution.  Standards were prepared as shown in table 4. 
The working DMMB dye solution was prepared by mixing glycine (40.5 
mM), NaCl (40.5mM), and hydrochloric acid (9.5 mM). After dissolution, 16 mg 
DMMB was added to 1 liter of this solution, pH was adjusted to 3 and the dye 
was stored in the dark at room temperature.  The assay was carried out in a plate 
reader in a 96 well plate format.  Eight microliters of sample or standard and 200 
µl of dye were added to each well and allowed to incubate at room temperature 
for 2 minutes.  The plate was then read at a wavelength of 525 nm.  Negative 
controls used were PLLA constructs with no cells and positive controls were 
native cartilage samples.  The standard curve was plotted and values of GAG in 
the sample were obtained by linear interpolation.  
Construct Collagen Content 
The amount of collagen present in the constructs was determined by 
measuring the amount of hydroxyproline in the sample and multiplying by a factor 
of 9 to obtain total collagen (Woessner, 1961).  Hydroxyproline was used as a 
standard for the assay.  Briefly, a working solution of 1 mg/ml of hydroxyproline 
was made and subsequent standards in the range of 0-50 µg were prepared.  
Aliquots of samples (under 10 µg/ml) and standards were prepared in glass 
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tubes and 2N NaOH was added to this solution. Samples and standards were 
diluted in an acetate buffer containing 120 mg/ml sodium acetate, 46 mg/ml citric 
acid, and 34 mg/ml sodium hydroxide with pH 6.5.  The total volume was brought 
up to 50 µl.  The samples were then hydrolyzed by autoclaving at 121°C and 15 
psig.  A solution of Chloramine-T was prepared by dissolving 1.27g of 
Chloramine-T in 20 ml n-propanol and making the solution up to 100 ml using dI 
water.  All solutions were prepared just before use.  Four hundred and fifty 
microliters of Chloramine-T was added to the hydrolyzed sample and incubated 
for 25 minutes at room temperature.  The Ehrlich’s reagent was prepared while 
the sample was incubated with Chloramine-T.  The reagent consisted of 15 g of 
p-diaminobenzaldehyde in 100 ml of a 2:1 solution (v/v) of n-propanol and 
perchloric acid.  Five hundred microliters of the reagent was added to the sample 
containing Chloramine-T and incubated at 65°C for 25 minutes.  The samples 
were transferred to cuvettes and read in a spectrophotometer at 540 nm.  The 
hydroxyproline content in the sample was determined by linear interpolation of 
the standard curve.  
Collagen type II ELISA 
To detect the presence of collagen types I and II, a semi quantitative 
enzyme linked immunosorbent assay (ELISA) was performed.  The total amount 
of protein in the construct was measured by the method of Bradford using a 
protein determination kit (BioRad, Hercules, CA).  The digestate was diluted in 
1X phosphate buffered saline (PBS), pH 7.2 to a final protein concentration of 
approximately 20 µg/ml.  Fifty microliters of the sample was coated on a 96 well 
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polystyrene plate.  Standards used were bovine collagen type II and bovine 
collagen type I.  After coating the plates for 1 hour at 37°C, non specific protein 
blocking was performed by the addition of a 1% bovine serum albumin solution in 
PBS (1%BSA/PBS).  After blocking for 30 minutes, the blocking solution was 
removed from the wells and primary antibody was added.  To detect background 
generated due to secondary antibody binding, each sample was added in two 
wells in the 96 well plate. One well was exposed to both primary and secondary 
antibodies while the control well was exposed only to secondary antibody.  
Primary antibodies for type II collagen and procollagen type I were obtained from 
the Development Studies Hybridoma Bank (University of Iowa).  Primary 
antibodies were diluted 1:15 and secondary antibody (goat-anti-mouse) was 
diluted 1:1000.   All antibody dilutions were in 1% BSA/PBS.  After primary 
antibody incubation for an hour at room temperature, the wells were washed with 
0.05% Tween-20 in PBS (PBS-T) three times.  The secondary antibody was 
added and incubated for an hour at room temperature.  After washing the excess 
secondary antibody, the antibody conjugate was detected by means of o-
phenylenediamine dihydrochloride peroxidase substrate (Perlmann and 
Perlmann, 1994).  The optical density was read using a spectrophotometer at 
450 nm and amount of type II and type I collagen were determined by using a 




35 day constructs were washed in PBE immediately after harvest.  The 
constructs were fixed in 10% neutral buffered formalin and stored at 4°C for up to 
a week. Post-fixation, the samples were incubated in 15% sucrose overnight.  
This allowed the sucrose solution to penetrate the pores of the tissue and replace 
the formalin.  Then the constructs were embedded in an optimal cutting 
temperature medium containing 10% poly vinyl alcohol.  Sections 7-µm through 
the construct thickness were made using a cryostat on to plain glass slides. The 
sections were stored at -80°C until ready for staining.  
Before staining, the slides were air-dried for 20 minutes.  The slides were 
then fixed in acetone for 5 minutes.  The slides were air-dried again to remove 
any traces of acetone.  The slides were stained for cell nuclei (Hematoxylin & 
Eosin), GAG (safranin-O) and collagen (Masson’s trichrome).  
Immunofluoresence was used to detect the presence of collagen type II. 
 
Confocal Microscopy 
The cell viability inside constructs was assessed after 4 days in the 
seeding efficiency studies using the live/dead assay kit (Molecular Probes Inc., 
OR).  The protocol accompanying the kit was followed to stain the cells with 
Calcein-AM and ethidium homodimer to visualize live and dead cells.  20 µL of 
the supplied 2 mM ethidium homodimer stock solution was added to 10 mL of 
sterile, PBS, vortexing to ensure thorough mixing.  To this solution, 5 µL of the 
supplied 4 mM calcein AM stock solution was added.  The resulting working 
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solution had  approximately 2 µM calcein AM and 4 µM ethidium homodimer.  
The working solution was added to freshly harvested construct rinsed briefly in 


































Table 5: Hematoxylin and eosin protocol 
 
Step Procedure # of washes Duration
1 Xylene 3 3 min 
2 100 % alcohol 3 2 min 
3 95 % alcohol 2 2 min 
4 70% alcohol 1 2 min 
5 dI water 1 2 min 
6 Hematoxylin 1 0.5-1 min
7 0.5% acid alcohol 1 1 dip 
8 Water 1 1 
9 Bluing reagent 1 30 sec 
10 Water 1 1 min 
11 95 % alcohol 1 1 min 
12 1% alcoholic eosin 1 30 sec 
13 95% alcohol  1 30 sec 
14 100% alcohol 3 1 min 
15 Xylene 3 1 min 





Table 6: Safranin-O staining for glycosaminoglycan 
 
Step Procedure # of washes Duration
1 dI water 1 1 min 
2 Weigert’s hematoxylin 1 15 sec 
3 Tap water 1 2 min 
4 0.2% aq. fast green 1 1 min 
5 1% acetic acid 1 3 sec 
6 0.1% safranin-O 1 5 min 
7 95% alcohol 1 1 min 
8 Reagent alcohol 3 1 min 
9 Xylene 2 1 min 











Table 7: Masson’s trichrome staining for collagen 
 
Step Procedure # of washes Duration 
1 Rehydrate in dI water   
2 Bouin’s solution (at 56°C) 1 1 hour 
3 Tap water rinse 1 5 min 
4 dI water rinse 1 2 min 
5 Weigert’s hematoxylin 1 1-2 min 
6 Tap water 1 5 min 
7 Biebrich’s scarlet-acid fuchsin 1 5 min 
8 dI water rinse 1 2 min 
9 Phosphomolybdic-phosphotungstic acid 1 1 min 
10 Aniline blue 1 5 min 
11 1% acetic acid 1 5 min 
12 95% alcohol 2 1 min 
13 100% alcohol 2 1 min 
14 Xylene 3 1 min 





Table 8: Immunofluorescence for collagen II 
 
Step Procedure # of 
washes 
Duration
1 Rehydrate in 1 X PBS 2 5 min 
2 Antigen retrieval using pepsin (37°C) 1 20 min 
3 Wash in PBS 2 5 min 
4 Block 1% BSA/PBS 1 20 min 
5 1 antibody (1:1) diluted in 1%BSA/PBS 1 1 hour 
6 Wash in PBS 2 5 min 
7 Biotinylated 2 antibody diluted in 1% BSA/PBS 
(1:400) 
1 30 min 
8 Wash in PBS 2 5 min 
9 Avidin D (in dark) 1 30 min 
10 Wash in PBS 2 5 min 
11 DAPI (12.5 µg/ml) (in dark)  1 5 min 
12 Wash in PBS 2 5 min 






Culture medium samples were saved from every feeding (every 48 hours) from 
the bioreactors.  These samples were used to analyze for metabolic activity and 
the presence of soluble GAG and NO release in the medium.   
Glucose Measurement 
Medium glucose measurements were made using Trinder reagent.  One 
vial of the reagent was dissolved in 100 ml of dI water.  The assay was carried 
out in microwell format. One microliter of the medium sample was added to the 
well.  Pre-made standards (100 mg/dl, 300 mg/dl and 800 mg/dl) were obtained 
from Sigma Chemicals.  Two hundred microliters of the reagent was added to 
each well and the microplate was incubated at room temperature for 18 minutes.  
After incubation, the plate was read at 505 nm in a plate reader.  The initial 
concentration of glucose in the medium was measured using fresh DMEM.   
Lactate Measurement 
Medium lactate levels were measured using a lactate reagent (Trinity 
Biotech, Ireland).  The lactate reagent was prepared by dissolving 1 vial of the 
reagent in 10 ml of dI water.  The assay was performed in a microwell format.  
Standards were obtained from Sigma Chemicals (20mg/dl, 80 mg/dl and 120 
mg/dl).  Two microliters of the media sample was added to the well and 200 µl of 
the reagent was added.  The plate was incubated at room temperature for 10 min 
and then read in a plate reader 540 nm.  
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Soluble GAG Measurement 
The soluble GAG in the spent medium was measured using the DMMB 
dye similar to the construct GAG content.  Eight microliters of the medium was 
added to the microwell plate and 200 µl of the DMMB dye was added.  The plate 
was incubated at room temperature for 2 minutes and read in a plate reader at 
540 nm.   
Nitric oxide Measurement 
Nitric oxide is an unstable molecule and is converted to nitrate/nitrite in 
culture.  The release of nitric oxide by the cells in the culture medium was 
measured by determining the nitrate/nitrite content in the medium. The Griess’ 
reagent consists of 1% w/v sulfanilamide, 0.1% w/v napthylethylene diamine 
dihydrochloride and 2.5% phosphoric acid in dI water.  Standards were prepared 
using sodium nitrite 0.01 µg -0.06 µg.  Fifty microliters of sample was added to a 
microwell plate and then 50 µl of the reagent was added to the well.  The plate 




Measurement of Dynamic Shear Modulus 
Thirty five day samples for mechanical testing are frozen in PBE containing 
protease inhibitors solution at -20°C.  Prior to testing, the samples were allowed 
to thaw for 30 minutes at room temperature. The construct shear modulus was 
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measured using a Bohlin CVO® rheometer.  Two or three 4 mm biopsy punches 
were made from each construct.  The sample thickness was measured and 
noted.  A typical testing apparatus is shown in Figure 8.  The sample was placed 
on the rheometer base plate and preloaded using an impermeable platen.  The 
rheometer gap was set to 90% of the sample thickness to pre-load the sample.  
A small quantity of PBE with protease inhibitor cocktail was added to the base 
plate of the rheometer to maintain the sample hydration.  After the sample had 
equilibrated, the oscillation test was carried out.  The frequency sweep was 
carried out in the range of 0.01-1.0 Hz with logarithmic increase in the frequency.  
A typical test took about 15-20 minutes.  The measuring system was then backed 
off and the sample was transferred back to the pre-labeled tube.  This testing 
protocol causes very little change in the fluid volume of the construct and allows 


























Figure 9: Schematic of confined compression chamber and 







Figure 8: Schematic of the testing apparatus for the measurement 
of the shear modulus  
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Confined compression testing 
Confined compression testing was used to evaluate the flow dependent 
behavior of tissue engineered cartilage construct.  A confined compression 
testing chamber 4 mm in diameter was used to measure the aggregate modulus 
of the constructs on an ELF machine (EnduraTEC, Minnetonka, MN ).  A 
schematic of the testing apparatus is shown in Figure 9.  The testing apparatus is 
located in the mechanical testing core facility, in the IBB building. The construct 
thickness was measured and the construct was then placed in the confined 
compression chamber.  A porous steel platen was placed on the construct and 
the construct was preloaded to 0.01 N.  A stress relaxation test was initiated at 
strains of 5, 10, 15, 20%.  The stress was allowed to reach equilibrium for 15 
minutes.  The sample was kept in a bath of PBE with protease inhibitor during 
the testing.  The construct aggregate modulus was obtained by plotting 
equilibrium stress versus strain and calculating the slope.  In most cases, the 
linear regression had a correlation coefficient greater than 0.9.  
Statistical Analysis 
An experiment consisted of seeding the required number of bioreactors 
with chondrocytes from the same animal.  Different experiment within the same 
study used cells from different animals.  For each data set, the values are 
presented as mean ± SEM for n constructs pooled from N different experiments. 
Individual data sets for each parameter were tested for normality or Gaussian 
distribution.  If the data set was not normal, then a non-parametric test was 
carried out.  For normally distributed data, analysis for statistical significance was 
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carried out using a general linear model analysis of variance (ANOVA) (Hayter, 
1996).  For the mechanical testing correlation with construct extracellular matrix 
content, non-linear regression methods are used.  For the 35 day experiments, 
comparisons for determining statistical significance were carried out between 
conditions (for the pooled set of n constructs from N separate experiments) for 


































Many bioprocessing conditions affect the deposition of extracellular matrix 
in vitro.  For cartilage tissue engineering, a continuing challenge has been to 
identify conditions that a) increase extracellular matrix synthesis, b) increase 
construct material properties, and c) provide constructs with an ultrastructure 
similar to native tissue.  In this work, the main focus is on bioreactor design and 
operating conditions that address the factors listed above.   
The effects of surface shear stress on construct development are well 
documented for the concentric cylinder bioreactor (Saini, 2002; Saini and Wick, 
2003; Williams et al., 2002).  Based on these studies and the varying loading that 
the joint experiences in vivo, experiments were carried out to determine the effect 
of variable hydrodynamic loading on construct surface through the culture period.  
This involved the study of construct biochemical composition under two loading 
regimens: increasing hydrodynamic loading (IHL) and decreasing hydrodynamic 
loading (DHL).  The loading schedules are shown in Table 1 in the Background.  
Each loading regimen was studied separately with its own control.  The steady 
control for DHL was a bioreactor operated at 76 rpm throughout the culture time 
and the steady control for IHL was a bioreactor operated at 19 rpm throughout 
the culture time.   
Another well documented modulator of ECM synthesis in vitro is low 
oxygen tension (Murphy and Sambanis, 2001b; Murphy and Sambanis, 2001a).  
In the concentric cylinder bioreactor, constructs cultured at 5% oxygen tension 
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have higher GAG synthesis as compared to constructs cultured under 20% 
oxygen tension after 3 weeks in culture (Saini, 2002; Saini and Wick, 2003; 
Williams et al., 2002).  This study was extended to 5 weeks in the current work.  
The combined effect of hydrodynamic loading and low oxygen tension was also 
studied.  Some preliminary work on the modulation of constructs using TGF-β1 
has also been done.  
Effect of low oxygen tension at steady shear 
The primary objective of this experiment was to determine the effect of low 
oxygen tension (5%) on cartilage constructs cultured for 35 days in the 
concentric cylinder bioreactor culture.  The effect of 5% oxygen tension on 
construct development is documented for 22 days (Saini and Wick, 2004).  Two 
bioreactors were operated at 38 rpm in an oxygen tension environment of either 
20% or 5%.  For this study, only two experiments were carried out (n=6; N=2).  
The construct biochemical composition is shown in Figure 10.   In either 
oxygen tension, robust cell proliferation was observed and the construct cell 
number did not vary largely over the culture period (Figure 10A).  After 35 days, 
the constructs from the bioreactor operated in normoxia had 15 ±5 million 
chondrocytes per construct and constructs from the bioreactor operated in 5% 
oxygen tension had 24 ± 1.8 million cells per construct.  The construct collagen 
content is shown in Figure 10C.  The construct collagen content was similar in 
20% and 5% oxygen tension on day 12 (0.99 ± 0.13 mg/construct and 0.8 ± 0.06 
mg/construct respectively).  On day 24, construct collagen content was higher in 
the 5% oxygen tension bioreactor (1.3 ± 0.15 mg/construct) as compared to 20% 
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oxygen tension (1.0 ± 0.15 mg/construct). On day 35, the construct collagen 
content was 1.45 ± 0.09 mg/construct in the 5% oxygen tension bioreactor, 1.5-
fold more than the collagen content in the constructs cultured in the 20% oxygen 
tension bioreactor (0.95 ± 0.16 mg/construct).  The construct GAG content in the 
5% oxygen tension was also higher as compared to the construct GAG content in 
the 20% oxygen tension (Figure 10B) (5.16 ± 0.8 mg/construct as compared to 
3.28 ± 0.37 mg/construct). 
Thus, low oxygen tension culture increased construct extracellular matrix 















































Figure 10: Effect of low oxygen tension on construct development.  Data are 
mean ± SEM for n=6 constructs from N=2 experiments (A) 











































Effect of decreasing hydrodynamic loading on construct development 
The main objective of this study was to determine the effect of decreasing 
hydrodynamic loading (DHL) on construct biochemical composition. Two 
bioreactors were operated at 20% oxygen tension, one run at 76 rpm, the other 
bioreactor at DHL (Table 1, Background) for 35 days. 
Chondrocytes exhibited approximately a 2-fold increase in cell number 
from the initial seeding number of 6.25 million cells per construct in the first 12 
days of bioreactor culture.  The constructs contained 11.6 ± 2.7 million 
cells/construct in 76 rpm as compared to 12.3 ± 2.7 million cells/construct in DHL 
(Figure 11A) on day 12.  On day 24, the chondrocyte population in the 76 rpm 
regimen was 11.7 ± 2.7 million chondrocytes/construct as compared to 4.6 ± 1.2 
million chondrocytes/construct  in DHL (Figure 11A). On day 35, the construct 
cell numbers were 18.7 ± 7.7 million chondrocytes/construct in 76 rpm and 13.1 ± 
2.7 million chondrocytes/construct in DHL (Figure 11A).   
The construct GAG content was 3.7 ± 0.8 mg GAG/construct in 76 rpm as 
compared to 4.6 ± 0.6 mg GAG/construct (Figure 11B) on day 12.  On day 24, 
the construct GAG content was similar in either bioreactor hydrodynamic loading, 
the values being 3.8 ± 0.9 mg GAG/construct and 4.3 ± 0.9 mg GAG/construct in 
76 rpm and DHL respectively.  At the end of culture on day 35, the construct 
GAG content was higher in DHL at 7.2 ± 0.5 mg GAG/construct as compared to 
5.1 ± 0.5 mg GAG/construct in 76 rpm.  This increase in construct GAG was 
statistically significant (* p<0.05). 
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On day 12, the construct collagen content was 3.7 ± 0.9 mg 
collagen/construct in 76 rpm as compared to 2.5 ± 0.5 mg collagen/construct 
(Figure 11C).  On day 24, the construct collagen content was similar between 76 
rpm and DHL at 2.1 ± 0.5 mg collagen/construct and 2.3 ± 0.6 mg 
collagen/construct respectively.   After 35 days in bioreactor culture, the construct 
collagen content was lower in DHL as compared to 76 rpm, the values are 1.9 ± 
0.6 mg collagen/construct and  3.7 ± 0.6 mg collagen/construct, respectively ( NS 
p = 0.08). 
Thus, decreasing hydrodynamic loading increases construct GAG content 
by ~40% after 35 days in bioreactor culture as compared to steady loading at 76 
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Figure 11: Effect of DHL on construct development. Data are mean ± SEM for 
N=4 experiments, n=10-16 constructs (A) Chondrocytes per construct (in 
millions), (B) GAG per construct (mg), (C) Collagen per construct (mg).  The 
construct GAG content is significantly higher on day 35 for DHL as compared to 
76 rpm (*p<0.05) 
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Effect of increasing hydrodynamic loading on construct development 
The primary objective of this study was to determine the effect of 
increasing hydrodynamic loading on construct development.  The increasing 
hydrodynamic loading regimen follows the opposite trend of the decreasing 
hydrodynamic loading regimen. The idea behind this loading regimen was to 
disseminate the effect of varying shear stress on construct surface over the 
culture period.  This study was designed after the decreasing hydrodynamic 
loading was carried out.  The main objective of this study was to see if increasing 
hydrodynamic loading would further enhance construct extracellular matrix 
deposition.  
As in most of the bioreactor experiments, cell proliferation is robust in 
either bioreactor condition (Figure 12A).  After 12 days in the bioreactor, the 
chondrocyte content per construct was 3.1 ± 0.6 million in the bioreactor 
operated at 19 rpm and 5.8 ± 0.5 million in the bioreactor operated under the 
increasing hydrodynamic loading regimen.  The cell content was similar on days 
24 and 35.  In the 19 rpm bioreactor, the cell content was 9.4 ± 1.44 and 16.1 ± 
1.9 million chondrocytes per construct on days 24 and 35 respectively.  In the 
increasing hydrodynamic loading regimen, the cell content was 6.3 ± 0.7 and 
11.1 ± 0.9 million chondrocytes per construct on days 24 and 35 respectively.  
Construct collagen content was similar on day 12 and 24 (Figure 12B). In 
the 19 rpm bioreactor, construct collagen content was 1.2 ± 0.1 and 1.0 ± 0.1 mg 
per construct on days 12 and 24 respectively whereas in the IHL bioreactor, the 
construct collagen content was 1.1 ± 0.1 and 1.3 ± 0.07 mg per construct on 
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days 12 and 24 respectively.  On day 35, the construct collagen content was 
slightly higher in the IHL bioreactor.  The construct collagen content was 1.6± 0.2 
and 2 ± 0.3 mg per construct in the 19 rpm and the IHL bioreactor respectively 
(NS p<0.1).   
The construct GAG content showed similar trends for days 12 and 24 in 
the 19 rpm and the IHL bioreactor (Figure 12C).  In the 19 rpm bioreactor, 
construct GAG content was 2.3 ± 0.3 and 3.9 ± 0.5 mg per construct on days 12 
and 24 respectively.  In the IHL bioreactor, construct GAG content was 2.8 ± 0.5 
and 2.1 ± 0.4 mg per construct on days 12 and 24 respectively.  On day 35, the 
19 rpm had higher GAG content at 7.8 ± 1.6 mg per construct and in the IHL 
bioreactor 5.3 ± 0.5 mg per construct (NS p<0.1).  
The increasing hydrodynamic loading regimen does not show an increase 
in construct GAG and collagen as compared to the steady loading of 19 rpm.  
The construct GAG content was higher in the 19 rpm bioreactor indicating that 
the increasing hydrodynamic loading was not as favorable to construct 

















































Figure 12: Effect of IHL on construct development.  Data are mean ± SEM from 
N=3 experiments, n=14-19 constructs (A) Chondrocytes per construct (in 
millions), (B) GAG per construct (mg), (C) Collagen per construct (mg). No 


































 Histological analyses of the constructs under the four loading conditions 
are presented here.  Routine hematoxylin and eosin stains showed the presence 
of cells (Figure 13).  Residual polymer (marked by arrows) was observed as 
transclucent material in the sections. Very little residual polymer was seen in 
most sections.  The 76 rpm construct had a ‘holey’ appearance and it was not 
immediately apparent whether this was due to a processing artifact or due to the 
nature of the construct.   
 Masson’s trichrome stain for collagen (Figure 14) showed the presence of 
collagen in all the samples.  The collagen fibers stain blue in the construct.  The 
staining in the 76 rpm construct was most intense despite the appearance of the 
construct.  However, the fibers did not seem aligned but rather ‘bunched up’ in 
this construct as compared to the other sections.   
Safranin-O staining for GAG showed the presence of GAG in all the 
sections (Figure 15).  The GAGs are stained orange-red in the constructs.  The 
decreasing hydrodynamic loading had the most intense stain for GAG.  Very little 
GAG was seen in the 76 rpm constructs.  The 19 rpm and the increasing loading 
constructs were characterized by large parts of the section where no stain for 
GAG was observed.   
Immunofluorescence for collagen type II (Figure 16) showed the presence 
of type II collagen in all the constructs.  The decreasing loading construct had the 
most uniform distribution of the type II collagen while 76 rpm had the most 
random distribution.  Less intense staining was seen for 19 rpm and increasing 
loading. 
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76 rpm Inside the construct   Outside the construct 
          
DHL Inside the construct   Outside the construct 
          
19 rpm Inside the construct   Outside the construct 
          
IHL Inside the construct   Outside the construct 
          
 
Figure 13: H & E stain for constructs. Images are all taken at 20X with the same 
light intensity for all the sections.  The cell nuclei are stained dark purple and the 
extracellular matrix is light pink in color.  Remnants of the polymer scaffold are 
seen as translucent parts, marked by arrows. 
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76 rpm Inside the construct   Outside the construct 
        
DHL Inside the construct   Outside the construct 
        
19 rpm Inside the construct   Outside the construct 
         
IHL Inside the construct   Outside the construct 
        
 
Figure 14: Masson’s trichrome stain for collagen.  Images are taken at the same 
light intensity for all sections. The cell nuclei are stained dark purple and the 




76 rpm Inside the construct   Outside the construct 
       
DHL Inside the construct   Outside the construct 
       
19 rpm Inside the construct   Outside the construct 
       
IHL Inside the construct   Outside the construct 
       
 
Figure 15: Safranin-O stain for GAG.  The images are taken at 20X magnification 
at the same light intensity for all sections.  The cells in the sections are stained 
black and the GAG is stained orange-red.  In the 19 rpm, IHL and 76 rpm 
sections, there are areas of the construct that do not stain for GAG, marked by 
arrows.  
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76 rpm Inside the construct   Outside the construct 
          
DHL Inside the construct   Outside the construct 
          
19 rpm Inside the construct   Outside the construct 
          
IHL Inside the construct   Outside the construct 
          
 
Figure 16: Immunofluorescence for type II collagen. The images were taken 
using a fluorescent microscope.  The cell nuclei are stained blue using the 




Effect of combining decreasing hydrodynamic loading with low oxygen 
tension 
In the two different hydrodynamic loading regimens compared in this 
study, the decreasing hydrodynamic loading regimen had the most favorable 
effect on construct GAG deposition.  Overall, decreasing loading increased 
matrix GAG accumulation whereas increasing hydrodynamic loading decreased 
accumulation of GAG in the construct matrix, compared to their respective steady 
hydrodynamic loading controls.  In contrast, hydrodynamic loading conditions 
only marginally affected collagen accumulation.  Therefore, the low oxygen 
studies were carried out in the bioreactor with decreasing hydrodynamic loading 
regimen as the mechanical stimulation.  Based on the results of the DHL 
regimen, and the low oxygen tension studies, these two stimuli were combined in 
an attempt to increase construct collagen content.  
Chondrocyte proliferation was robust in both 20% oxygen tension and 5% 
oxygen tension cultures.  The initial cell seeding number on day 0 was 6.25 
million chondrocytes per construct in either oxygen tension.  After 35 days in 
bioreactor culture, cell proliferation was similar at both oxygen tensions with cell 
numbers being 38 ± 9 and 24 ± 6 million chondrocytes per construct for 5% and 
20% oxygen tension culture conditions (Figure 17A).  The chondrocyte number 
per construct was 57 % higher in low oxygen tension after 35 days culture as 
compared to normoxia, although this difference is statistically not significant. 
Construct GAG composition (Figure 17B) was 13.4 ± 3.2 mg per construct 
in low oxygen tension bioreactor culture and higher than that observed in the 
20% oxygen tension culture (5.5 ±1.6 mg GAG per construct) after 12 days.  
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Construct GAG levels increased during culture for both oxygen tension 
conditions between 12 and 24 days.  After 35 days, culture under low oxygen 
tension led to an overall 40% increase in GAG composition in constructs 
compared to culture in 20% oxygen tension (15.8 ± 3.3 DHL, 11.6 ± 3.4 mg GAG 
per construct, respectively).  However, the difference in GAG composition was 
not significantly different in constructs cultured under 5% or 20% oxygen tension 
at any time point.   
Construct collagen content was higher at all time points in low oxygen 
tension bioreactor culture as compared to normoxic culture (Figure 17C).  After 
24 days culture, constructs cultured at 5% oxygen tension contained 8.0 ± 1.8 
mg collagen per construct as compared to 1.8±0.4 mg collagen  per construct (*p 
< 0.05) for constructs cultured in 20% oxygen tension.  After 35 days culture, 5% 
oxygen tension constructs had 6.5±1.4 mg collagen/construct as compared to 
2.1±0.5 mg collagen/construct in the 20% oxygen tension cultures (*p < 0.05).  
Indirect ELISA for collagen type II content in the constructs showed trends 
similar to that of total collagen content in the construct.  Greater than 70% of the 
total collagen content in the construct was type II collagen.  After 35 days in 
bioreactor culture, the type II collagen content was 6.3±1.8 mg/construct in 
hypoxia and 2.4±1.0 mg/construct in normoxia (Figure 18A). The type II collagen 
content was higher for constructs cultured under 5% oxygen tension as 
compared to constructs cultured under 20% oxygen tension at all time points.  
Type I collagen ELISA showed that less than 0.5 mg was collagen I was present 
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Figure 17: Construct composition under low oxygen tension with decreased 
hydrodynamic loading. Data are mean ± SEM from N=3 experiments for 20% 
oxygen tension + DHL and N=4 experiments for 5% oxygen tension + DHL. 
(n=12-20 constructs) (A) Chondrocytes per construct (in millions, (B) GAG per 





















































Figure 18: Construct collagen characterization for low oxygen tension in the 
presence of decreasing hydrodynamic loading. Data are mean ± SEM from N=3 
experiments for 20% oxygen tension + DHL and N=4 experiments for 5% oxygen 











The dynamic shear modulus of constructs cultured in the presence of both 
low oxygen tension and decreasing hydrodynamic loading was measured to 
determine the stiffness of the construct.   
The dynamic shear modulus for constructs cultured under 5% oxygen 
tension with decreasing hydrodynamic loading is higher at all frequencies of 
measurement compared to 20% oxygen tension culture with decreasing 
hydrodynamic loading (Figure 19A).  Constructs cultured in 20% oxygen tension 
have shear moduli of 131 ± 26 kPa at 1Hz, 67 ± 23 kPa at 0.1 Hz and 64 ± 20 
kPa at 0.01Hz.  The constructs cultured in hypoxia have shear moduli of 345 ± 
213 kPa at 1 Hz, 285 ± 171 kPa at 0.1Hz and 247 ± 152 kPa at 0.01Hz.  At all 
frequencies of testing, the shear modulus at 5% was higher than at 20% oxygen 
tension.  The values of shear moduli are significantly higher at 5% oxygen 
tension than 20% oxygen tension at 0.01 Hz and 0.1 Hz (*p < 0.05).  The 
increase in the dynamic shear moduli of the constructs with frequency indicates 
that the construct rheological properties are frequency dependent.  The phase 
angle or loss angle (δ) is shown in Figure 19B.  
The dynamic shear modulus of PLLA scaffolds soaked in complete culture 
medium for 35 days either under 5% or 20% oxygen tension was measured to 
compare the behavior of polymer alone versus constructs containing extracellular 
matrix components.  The shear moduli of the scaffolds were in the same range 
as that of the constructs (Figure 20).  However, while the constructs remained 
intact after the testing process, the polymer scaffolds exhibited cracks on the 
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surface and disintegrated into fine powder at the end of the testing process 
indicating that the scaffolds are fragile.  The frequency dependence of the shear, 
viscous and elastic modulus is different for the scaffold than from the construct 
and the sudden increase in the moduli between 0.1 Hz and 1.0 Hz indicates that 
the scaffold is brittle and cannot withstand high impact loading or testing.    
Combining low oxygen tension with decreasing hydrodynamic loading 
increased construct collagen content 3-fold and GAG content by ~40%.  The 
dynamic shear modulus for the constructs was higher for the constructs cultured 
under low oxygen tension with decreasing hydrodynamic loading by ~3-4 fold.  
This indicated that the combination of these conditions is favorable for increasing 
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Figure 19: Construct dynamic shear modulus and phase angle for constructs 
cultured under low oxygen tension and decreasing hydrodynamic loading. Data 
are mean ± SEM from N=3 experiments for 20% oxygen tension and N=4 for 5% 




























Figure 20: Shear modulus of unseeded PLLA scaffolds soaked in complete 
DMEM for 35 days under 20% and 5% oxygen tension.  Data are mean ± SEM 
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  Comparing the DHL + 5% oxygen and DHL + 20% oxygen, constructs 
from either culture condition show uniform chondrocyte distribution through the 
construct thickness.  Chondrocytes cultured in a  5% oxygen tension have a 
more rounded morphology as compared to chondrocytes cultured under 20% 
oxygen (Figure 21).  Staining for collagen and GAG is more intense in the low 
oxygen tension as compared to normoxic constructs when observed under light 
microscopy, consistent with higher matrix accumulation under hypoxia as shown 
in Figures 17 and 18.  Type II collagen was found in both the normoxic and 















    5% O2 + DHL       20% O2 + DHL 
   
   
    
   
Figure 21: Histology images for constructs cultured under low oxygen tension 
and DHL.  Shown are representative stains for cells, GAG, collagen and type II 
collagen. 








 The conditioned medium from the bioreactor was saved for biochemical 
analyses every time medium was changed.  Table 9 shows the NO production in 
different bioreactor conditions measured by nitrate/nitrite accumulation. On day 
12, the NO production was lowest in the 19 rpm and IHL bioreactors.  In the DHL 
bioreactor, as the shear stress decreased over culture period, the NO production 
changed, with the production being lowest between days 24 and 35.  There were 
no trends or significant differences observed in the DHL between 5% and 20% 
oxygen over the culture period.   
 
 
Table 9: NO production in the different bioreactor conditions.   
 
Bioreactor  12 day 24 day 35 day 
76 rpm 0.09 ± 0.02  0.111 ± 0.018 0.08 ± 0.02 
DHL 0.12 ± 0.01 0.153 ± 0.038 0.09 ± 0.03 
19 rpm 0.06 ± 0.03 0.03 ± 0.008 0.02 ± 0.005 
IHL 0.06 ± 0.04 0.07 ± 0.02 0.03 ± 0.01 
DHL 20% oxygen 0.14 ± 0.08 0.10 ± 0.04 0.10 ± 0.03 









Effect of TGF-β1 at steady shear stress 
TGF- β1 is a known modulator of chondrocyte response in vitro.  To 
assess the effect of TGF- β1 in bioreactor culture, two bioreactor conditions were 
compared.  The control bioreactor was operated at 38 rpm with complete DMEM.  
The test bioreactor was operated at 38 rpm with complete DMEM and 0.2 ng/ml 
of TGF-β1.  The experiment was run for 24 days.   
Chondrocyte proliferation in the presence of TGF-β1 is much higher 
compared to chondrocyte proliferation in the control bioreactor (Figure 22A).  
After 12 days in bioreactor culture, the TGF- β bioreactor had 65 million cells per 
construct and the control bioreactor had 8.2 million chondrocytes.  Between 12 
and 24 days, the cell population in the presence of TGF- β1 decreased to almost 
half.  The construct collagen content was similar in either culture condition, on 
day 12 either bioreactor yielded constructs with approximately 0.7 mg collagen 
and on day 24, about 2.2 mg (Figure 22C).  However, the construct GAG content 
was higher on days 12 and 24 in the presence of TGF-β1 almost twice as much 
as in the control bioreactor.  The constructs in the control bioreactor had 4.5 mg 
and 5.3 mg GAG per construct on days 12 and 24 respectively. The constructs 
cultured in the presence of TGF-β1 had 8.4 and 9.2 mg GAG per construct on 
days 12 and 24 respectively (Figure 22B).  This preliminary experiment indicated 
that the presence of TGF-β1 was beneficial to chondrocyte proliferation early in 


















































































Figure 22: Effect of TGF- β1 on construct development. Data are from one 
experiment. (A) Chondrocytes per construct (in millions), (B) GAG per construct 
(mg), (C) Collagen per construct (mg) 
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Effect of TGF-β1 in the presence of decreasing hydrodynamic loading  
 Among the different hydrodynamic loading regimens studied, the 
decreasing hydrodynamic loading has the most beneficial effect on construct 
GAG accumulation in normoxia.  In order to determine if the combined presence 
of TGF-β1 and decreasing hydrodynamic loading would enhance construct 
extracellular matrix further, experiments were carried out to determine the effect 
of 0.2 ng/ml of TGF-β1 in the decreasing loading regimen. 
  The constructs cultured in the presence of TGF-β1 and DHL contained 
32.1 ± 12.2 million cells/construct (Figure 23A) on day 12.  On day 24, the 
chondrocyte population in the construct decreased to 8.3 ± 1.6 million 
chondrocytes/construct.  On day 35, the construct cell number is 10.2 ± 1.5 
million chondrocytes/construct.   
The construct GAG content was 4.1 ± 0.7 mg GAG/construct (Figure 23B) 
on day 12.  On day 24, the construct GAG content was 4.3 ± 0.6 mg 
GAG/construct.  At the end of culture on day 35, the construct GAG content was 
4.5 ± 0.5 mg GAG/construct. 
On day 12, the construct collagen content was 3.0 ± 0.9 mg 
collagen/construct (Figure 23C).  On day 24, the construct collagen content was 
3.3 ± 0.9 mg collagen/construct.   After 35 days in bioreactor culture, the 
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Figure 23: Effect of TGF- β1 with DHL. Data are mean ± SEM from N=4 
experiments. (A) Chondrocytes per construct (in millions), (B) GAG per construct 
(mg), (C) Collagen per construct (mg) 
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Perfusion shear flow bioreactor 
The perfusion bioreactor was designed to incorporate the hydrodynamic 
loading features of the concentric cylinder bioreactor along with perfusion flow to 
enhance the ultrastructure of tissue engineered cartilage.  This bioreactor was 
characterized for some of the basic functionalities of tissue engineering 
bioreactors.  The first study carried out in the bioreactor was to determine 
seeding efficiency and cell viability in the constructs early in culture.  Four 
constructs each were harvested on days 2, 3 and 4 post-seeding.  One construct 
each was used for confocal imaging of live/dead cells and histology. The 
construct cell content was determined by the DNA assay.  The initial cell seeding 
was 150 million cells per 16 constructs which is about 9.375 million chondrocytes 
per construct.  After 2 days, only 1 million chondrocytes per construct had 
attached.  This amounted to a cell seeding efficiency of about 10%.  This could 
be because of the large volume of culture medium held in the outer cup (~ 500 
ml).  The chondrocyte content over the seeding period is shown in figure 24.  The 
chondrocyte content decreased from 1 million to about 0.5 million chondrocytes 
per construct.  This could be because of the cells not completely attached or 
being released in to the media because of the large porosity of the construct.  
The cell viability was high as is shown in Figure 25.  This showed that although 
the cell number decreases over the 4 day period, there is no evidence of cell 
death.  Decrease in cell number could also be because of potential nutrient 



























Culture time (days)  
Figure 24: Construct seeding in the perfusion bioreactor.  Construct cell numbers 




Figure 25: Chondrocyte viability: Live/dead assay showing chondrocyte viability 
after 4 days in the perfusion bioreactor 
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Short term construct development 
Short term construct development studies in the perfusion shear flow 
bioreactor were carried out for two weeks.  The seeding phase was carried out 
similar to the four day experiments with no perfusion flow. Perfusion flow was 
from day 4 to day 14.  Four constructs were harvested at each time point.   
 The construct cell proliferation showed an increase over time (Figure 
26A).  The chondrocyte number per construct increased from 1.2 ± 0.2 million 
per construct on day 4 to 3.3 ± 0.4 million per construct on day 14.  The construct 
cell number on day 14 was significantly higher than the construct cell number per 
construct on days 4 and 7.  This indicates that the presence of perfusion and 
shear is favorable for chondrocyte proliferation in the bioreactor.  The construct 
collagen content was 0.8 ± 0.14 mg per construct on day 4 and on day 14 it was 
1.2 ± 0.14 mg per construct (Figure 26B).  There was no significant change in the 
construct collagen content over the short culture period.  The construct GAG 
content showed an exponential increase over the culture period (Figure 26C).  
The construct GAG content increased from 3±0.4 mg per construct on day 4 to 














































































Figure 26: Short term construct development in the perfusion bioreactor: 14 day 
studies showing (A)construct cell number, (B)GAG per construct (mg) and (C) 




Long Term Construct development (35 days) 
To assess the growth of cartilage constructs long term in the perfusion 
concentric cylinder bioreactor, one long term 35-day study was carried out.  
Figure 27 shows a photograph of the cartilage construct taken immediately after 
harvest on day 35.  The construct has a glossy appearance characteristic of 
cartilage.  
Three constructs were harvested at each time point and analyzed for bulk 
composition.  Robust cell proliferation was observed over the 35-day period.  On 
day 4, the constructs had 0.5 ± 0.3 million chondrocytes per construct and this 
increased to 7.2 ± 0.13 million chondrocytes per construct on day 20 (Figure 
28A). There was a slight decrease in construct cell population between days 20 
and 35.  Construct collagen content was of the order of 1 mg per construct even 
after 35 days in culture (Figure 28C).  Construct GAG content was 6.5 mg per 
construct on day 35 indicating that GAG production in the perfusion bioreactor 
was robust (Figure 28B).   
Construct material properties were measured for 35-day constructs using 
both compression and shear testing.  Construct shear modulus was 33 kPa and 
compression modulus was 51 kPa (Figure 29).  Representative stress relaxation 
curve and linear regression is shown in Figure 30.  The stress relaxation curve 
and the high coefficient of regression (R2) confirm that within the range of strains 






Figure 27: Photograph of tissue engineered cartilage construct harvested from 
the perfusion shear flow bioreactor after 35 days in culture.  The appearance of 


















































































Figure 28: Long term construct development in the perfusion bioreactor.  Data 
are from n=3 constructs from one experiment. (A) Chondrocytes per construct (in 















Figure 29: Material properties of the construct. Construct equilibrium modulus 






















































Figure 30: Representative stress relaxation curves and linear regression to 





 These studies examine the effect of fluid induced shear stress (in varying 
hydrodynamic loading and perfusion flow) and low oxygen tension on tissue 
engineered cartilage construct development.  As opposed to constructs cultured 
under varying hydrodynamic loading or low oxygen tension alone, combining 
both these conditions increased construct collagen content and dynamic shear 
modulus significantly.  In order to incorporate multiple fluid flow regimes, a 
perfusion shear flow bioreactor has been designed and used to grow cartilage 
constructs.  Preliminary results show that this bioreactor is capable of supporting 
chondrogenesis and is a potential tool for the development of functional cartilage 















Joint cartilage can withstand an astonishing amount of load and physical 
stress per tissue volume.  However, when the tissue is damaged, it exhibits 
limited capacity for self-repair.  Adult cartilage is anisotropic both in terms of cell 
and matrix morphology and material properties.  Formation and development of 
cartilage in the embryo is directed by an array of growth factors and signaling 
pathways in a uniquely timed sequence on specifically positioned and/or 
patterned mesenchymal cells.  From a tissue engineering perspective, the 
current state-of-the-art for in vitro construct development is the culture of cells 
seeded on a biodegradable polymer and cultured under stimulatory conditions 
(presence of growth factors, compressive loading, shear stress, perfusion, 
hydrostatic pressure etc.).  The end objective of cartilage tissue engineering is to 
target patients with osteoarthritis and offer a clinically relevant repair and 
regeneration process for already damaged joints (Caplan, 2003). 
The molecular structure of cartilage is the key to material properties and 
behavior of tissue-engineered cartilage.  This raises issues such as collagen 
content of the tissue and the molecular weight of proteoglycans that are laid by 
the chondrocytes in the tissue construct.  The proteoglycans cannot function 
without the collagen or vice-versa.  Rapid chondrogenesis can be achieved only 
if the native environment of adult articular cartilage is manipulated so that the 
deficiencies inherent to slow healing are overcome.  The use of primary 
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chondrocytes seeded at high population has been successful in achieving rapid 
integration of tissue engineered grafts to native tissue (Lohmander, 2003).  
In this work, we have studied using primary bovine chondrocytes and 
PLLA, the effects of shear stress, shear stress and oxygen tension and shear 
stress in the presence of perfusion in an attempt to understand the effect of 
culture conditions on chondrocyte extracellular matrix deposition.  Specifically, 
the effect of hydrodynamic loading in two separate loading schedules was 
examined. The effect of combined low oxygen tension with hydrodynamic loading 
was studied to increase construct extracellular matrix properties.  To incorporate 
multiple flow regimes, a perfusion concentric cylinder bioreactor has been 
designed and validated for the development of tissue engineered cartilage 
constructs with flow-induced alignment of cells.   
Effect of low oxygen tension on construct development 
Culture of tissue engineered cartilage constructs under low oxygen 
tension in the concentric cylinder bioreactor for 35 days showed an increase in 
construct collagen and GAG content, compared to normoxic cultures (Figure 10).  
While the collagen content was similar in either oxygen tension at day 24, there 
was an increase in construct collagen content at day 35.  There was no change 
in construct cell number in either oxygen tension.  
Comparing 5 and 20% oxygen tension in 22-day bioreactor cultures in the 
concentric cylinder bioreactor, the GAG production increased two-fold in tissue 
engineered cartilage constructs (Saini and Wick, 2004).  There was no change in 
construct cell number or collagen synthesis in the low oxygen tension culture as 
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compared to 20% oxygen tension.  In the current study, longer culture times 
showed an increase in construct collagen also, indicating that low oxygen tension 
is a favorable environment for long term culture of cartilage constructs.  
These results are not completely unexpected for chondrocytes because 
low oxygen tension is a familiar environment for cartilage.  The diffusion of 
oxygen is limited to <200 µm away from the blood vessel in the tissue.  Cartilage 
is about 1-3 mm away from a nutrient artery on the growth plate end and is 
surrounded by synovial fluid at the articulating surface.  Therefore, oxygen 
tension in native cartilage is low.  Thus, low oxygen tension is a key player in 
chondrocyte metabolism in vivo.   As seen in the present study, applying low 
oxygen tension in vitro, enhances construct extracellular matrix deposition.   
These results are supported by hypoxic culture studies in explants and 
monolayer cell culture.  Periosteal explant from rabbits were cultured at 1, 5, 15 
and 90% oxygen tension to study the role of oxygen tension in articular cartilage 
repair in explant culture.  The best results of chondrogenesis were obtained at 
15% oxygen tension, with maximal cartilage and type-II collagen formation.  
Cartilage formation in the entire periosteum was maximal in the range of 12-15% 
oxygen tension (O'Driscoll et al., 1997) and not in an anoxic or hyperoxic 
environment.  Thus, better chondrogenesis is observed in a moderately hypoxic 
environment.   
The effect of a range of oxygen tensions, from 1-90% was studied on 
chondrocyte DNA and matrix synthesis in explant culture (Ysart and Mason, 
1994).  In cultures incubated at 24% oxygen, GAG synthesis was maintained at a 
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steady elevated rate throughout the seven day period of the study.  Long term 
data was not available for this study, preventing us from drawing direct 
comparisons with our data.   
The oxygen tension dependence of bovine articular chondrocytes was 
studied in alginate bead culture.  This study showed that chondrocytes cultured 
under 10% oxygen tension had highest pellet volume when compared with 0.1, 5 
and 20% oxygen tension (Grimshaw and Mason, 2000).  Proteoglycan 
aggregation was higher at oxygen tensions between 3-9% oxygen tensions as 
compared to proteoglycan aggregation between 13-60% oxygen tension (Clark et 
al., 1991).  
In our study, we picked an oxygen tension of 5% because the oxygen 
tension of cartilage in vivo is between 3-8 % and as mentioned before, oxygen 
tensions lower than 1% are not beneficial for extracellular matrix deposition.  
Comparing the current results with the literature, 5% oxygen tension has 
favorable effect of chondrogenesis and extracellular matrix deposition in vitro and 
we have used this value in further studies.   
Effect of varying hydrodynamic loading on construct development 
Fluid induced shear stress and interstitial fluid flow play an important role 
in eliminating mass transport gradients in tissue development in vitro.  
Additionally, fluid induced shear stress plays an important role in providing 
mechanical stimulation to chondrocytes to enhance matrix deposition in the 
constructs.  Shear stress studies on chondrocytes have focused on maintaining 
the same level of shear throughout the culture period.  Changing the shear stress 
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over the culture time as in oscillating shear stress mitigated the loss of GAG from 
the constructs in the concentric cylinder bioreactor (Saini and Wick, 2003).  A 
challenge for cartilage tissue engineering is identifying and understanding the 
nutrient and mechanical loading conditions that optimize tissue production.  
Previous studies in the concentric cylinder bioreactor have shown that 
chondrocyte matrix deposition is a complex function of  steady shear stress, with 
lower shear forces favoring collagen deposition whereas GAG accumulation is 
higher at higher shear loading (Saini and Wick, 2003).  Oscillatory loading 
between higher and lower shear mitigates the ~60% drop in matrix GAG 
deposition.  Based on this prior information, hydrodynamic loading schedules 
have been devised for varying shear stress on construct surface.  By using 
decreasing hydrodynamic loading, it has been shown that sequentially 
decreasing the hydrodynamic loading during culture leads to ~40% increase on a 
per construct basis in matrix GAG deposition in long term culture (Figure 11B).  
In contrast, the construct collagen content was higher in the constructs cultured 
under 76 rpm by ~ 50% as compared to constructs under decreasing 
hydrodynamic loading.  When the reverse order of shear stress was followed, as 
in the increasing hydrodynamic loading schedule, the GAG levels in the construct 
at steady rotation of 19 rpm reached similar levels as the DHL but the collagen 
levels were lower at all time points.   
The justification for varying shear stress during culture is supported by cell 
signaling studies.  As opposed to constant shear stress on construct, it has been 
shown that long-term intermittent shear deformation improves the cartilaginous 
 111
tissue formation in vitro.  Shear stress at constant levels increases the 
expression of inflammatory cytokines such as TIMP-1, IL-6 and MMPs, 
suggesting that long-term exposure to shear stress at constant levels is 
unfavorable for cartilage development in vitro.  This idea is supported by studies 
where application of long-term intermittent shear stress in fact promotes cartilage 
matrix synthesis (Waldman et al., 2003b).  Direct application of low amplitude 
shear forces increased expression of collagen and not proteoglycans in cartilage 
explants.  After 4 weeks of cyclic shear stress, collagen content increases by 
40% and proteoglycan content increased by 35% in 3-D constructs with bovine 
chondrocytes.  Tissues formed in the presence of shearing forces also displayed 
a 3-fold increase in compressive load bearing capability and 6-fold increase in 
stiffness.   
Thus, varying the hydrodynamic loading or outer cup rotation in the 
concentric cylinder bioreactor was used to incorporate the above ideas of 
intermittent biophysical stimulation.  The decreasing hydrodynamic loading 
regimen was chosen based on the GAG accumulation kinetics presented in 
(Saini and Wick, 2003).  We expected to see an increase in construct GAG and 
collagen contents in the decreasing hydrodynamic loading regimen as opposed 
to the steady shear of 76 rpm.  However, the GAG increase was only about 40% 
on a per construct basis and the decreasing loading did not increase construct 
collagen content.  This could be possibly be due to a complex response of the 
chondrocytes to the biophysical stimuli.  In contrast to the decreasing 
hydrodynamic loading, the increasing hydrodynamic loading did not show an 
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increase in GAG when compared to the steady control (19 rpm).  These results 
seem to suggest that the chosen stimuli and loading regimens may perhaps not 
be the most effective ones for increasing construct extracellular matrix 
production.  In addition, the response of the chondrocytes to the stimuli may be 
complicated, making it hard to discern differences at a macroscopic level.   
In monolayer bovine chondrocyte culture, fluid induced shear stress 
stimulated GAG synthesis by 2-fold and increased the length of the newly 
synthesized chains.  Dynamic shear stress on cartilage explants increases 
protein synthesis and proteoglycan significantly above the levels of statically 
cultured explants (Jin et al., 2001).  Shear stress at levels of 1.52 dyn/cm2 
increased GAG production by 2-fold in constructs with bovine chondrocytes after 
5 days of culture.  Nitric oxide release increased with the duration and magnitude 
of applied shear stress (Smith et al., 1995).  Shear stress also increased the 
expression of interleukin-6 and tissue inhibitor of metalloproteinase-1 (TIMP-1).  
A shear stress of 16.4 dyn/cm2 applied on human osteoarthritic chondrocytes 
cultured in monolayer increased NO release up to 3.5-fold over 24 hours as 
compared to static control.  Shear induced NO directly influenced regulation and 
coordination of the biomechanical responses of chondrocytes by altering matrix 
mRNA signal levels.  Inhibiting NO production significantly altered and reversed 
the inhibitory effects of shear stress on osteoarthritic chondrocytes (Lee et al., 
2002).  These results suggest that shear stress regulation of NO plays an 
important role in the response of chondrocytes to shear stress.   
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While the elucidation of specific signaling pathways was not the objective 
of this work, it should be noted that numerous signal transduction pathways are 
affected by shear stress.  Signaling mechanisms for detecting change in shear 
stress or loading possibly include stretch activated ion channels and integrin-
cytoskeleton machinery which can trigger kinase cascades leading to changes in 
protein expression and transcriptional regulation.  Mechanical stresses may also 
affect  chondrocyte synthesis of extracellular matrix by changing the structure of 
organelles such as endoplasmic reticulum and the Golgi apparatus (Grodzinsky 
et al., 2000). Chondrocytes respond favorably to dynamic mechanical stimulation 
by up-regulating proteoglycan synthesis.  Long term intermittent shear 
application and biomechanical conditioning on statically cultured constructs 
showed increased proteoglycan deposition (Waldman et al., 2003b; Waldman et 
al., 2003a).  One possible explanation for the response of chondrocytes to 
varying shear stress is that high initial stimulation increases matrix molecule 
biosynthesis. This may also explain the differences in the IHL and DHL 
schedules.   
There was no observed increase in the collagen content of the constructs 
cultured in the decreasing or increasing shear stress environment over the 
culture period.  The constructs cultured in 76 rpm environment indicated an 
increase in construct collagen content after 35 days (Figure 11C).  Thus, the 
response of chondrocytes to a varying shear stress regimen is complex and 
multiple biochemical pathways may be affected by a single shear stress loading 
regimen.  
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Two different hydrodynamic loading regimens were studied in this work.  
However, it is possible that intermittent application of high shear stress as 
opposed to continuous application (akin to intermittent dynamic stimulation) may 
hold the key to enhancing matrix deposition in the constructs.  
Effect of low oxygen tension and varying shear stress 
The bioreactor conditions outlined in the previous studies along with 
published results for the concentric cylinder bioreactor show that extracellular 
matrix deposition is a complex function of hydrodynamic loading (Saini and Wick, 
2003) and oxygen tension (Saini and Wick, 2004).  While these conditions 
stimulate GAG deposition, no significant changes in construct collagen content 
are observed.  The current study demonstrates that culture under hypoxia with 
decreased hydrodynamic loading dramatically increases collagen deposition and 
improves material properties of tissue engineered cartilage constructs in 
bioreactor culture.   
After 35 days in bioreactor culture, construct collagen content in the 
hypoxic environment with decreased hydrodynamic loading is 3-fold higher than 
the construct collagen content in the normoxic environment (Figure 17C).  Type II 
collagen is higher in 5% oxygen tension (Figure 18).  These results are in 
agreement with previous studies which show that, under hypoxic culture 
conditions,  chondrocyte collagen II mRNA levels (Grimshaw and Mason, 2001), 
collagen II mRNA transcription (Murphy and Sambanis, 2001b; Maroudas, 1980), 
and collagen II protein secretion (Hansen et al., 2001; Domm et al., 2002) 
increase with a decrease in oxygen tension in monolayer or aggregate cultures in 
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alginate beads.  Thus, combining decreasing hydrodynamic loading with low 
oxygen tension increases construct extracellular matrix deposition than either 
condition alone.  
Construct glycosaminoglycan content does not vary significantly between 
12 and 35 days in both hypoxic and normoxic bioreactor culture conditions, 
although at the end of culture, constructs cultured under decreased 
hydrodynamic loading in 5% oxygen tension have 40% higher GAG content 
compared to constructs cultured under decreased hydrodynamic loading in 20% 
oxygen tension.  These data suggest that the effect of low oxygen tension on 
matrix GAG synthesis is most prominent early in bioreactor culture.  The increase 
in GAG accumulation in constructs cultured in 5% oxygen tension may also result 
from better organization and incorporation of the small molecular weight 
proteoglycans in the extracellular matrix under hypoxic conditions.  This 
observation is consistent with previous data suggesting that  low oxygen tension 
environment increases the aggregation of newly synthesized proteoglycans 
(Clark et al., 1991).  The increase in GAG production early in bioreactor culture 
combined with possible aggregation of proteoglycans suggest that hypoxic 
environment can reduce bioprocessing time for cartilage tissue engineering in 
vitro.  
It is important to recognize here that decreasing hydrodynamic loading 
and low oxygen tension by themselves did not exhibit a large increase in 
construct collagen content, and showed only small increases in construct GAG 
content.  However, the combination of these stimuli seems to be synergistic and 
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leads to a large increase in construct collagen deposition and increases construct 
GAG deposition even early on in culture.  This effect may be attributed to multiple 
signaling pathways.  Some of the possibilities are presented here as speculation 
alone.   Ascorbic acid stimulates collagen production and the low oxygen tension 
environment may retain/promote the activity of ascorbic acid and reduce the 
activity of matrix metalloproteinases.  This action would allow for increased 
deposition of construct collagen content. Matrix metalloproteinases are known to 
trigger degradation of cartilage matrix.  In addition, they are also known to induce 
aggrecanase activity.  Therefore, the low oxygen tension environment may be 
inducing an environment that allows the hydrodynamic environment to enhance 
matrix deposition, thereby leading to synergistic effects.  
Constructs cultured in hypoxia with decreased hydrodynamic loading have 
a higher dynamic shear modulus as compared to constructs cultured in normoxia 
with decreased hydrodynamic loading.  After 35 days of  bioreactor culture, the 
shear modulus of constructs in hypoxia with decreased hydrodynamic loading 
culture is between 247 and 345 kPa (Figure 19) and within the range of 200-400 
kPa reported for native cartilage (Ratcliffe and Mow, 1996).  This increase in 
shear modulus in constructs containing more collagen suggests that bioreactor 
conditions that increase construct extracellular matrix content and organization 
lead to increases in viscoelastic properties of the construct.  This is consistent 
with previous reports that an increase in construct collagen content of 40% 
increases the compressive load bearing capacity 6-fold and stiffness 3-fold of 
engineered tissue formed in vitro (Waldman et al., 2003b).  These studies 
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indicate that the construct material properties depend on the construct matrix 
content.   
One of the physiologic functions of articular cartilage is to serve as a 
reservoir of elastic energy during locomotion, which saves muscular work and 
protects cartilage from fibrillation and fissure formation (Silver et al., 2002; Silver 
and Bradica, 2002). The energy storage capability is decreased or impaired in 
fibrillated or fissured tissue as is the case in osteoarthritis.  In arthritic joints 
because of the friction due to rough articulation and abraded joints, there is high 
energy loss due to joint motion.  This increases the strain on the muscle during 
motion and causes pain.  Identifying the mechanical function of the collagen 
network in native cartilage allows us to define a ‘functional’ goal for tissue 
engineering.  While measuring construct biochemical composition and material 
properties are established procedures of evaluating construct quality, the energy 
functions of the construct allow us to compare the construct directly to native 
cartilage in terms of functionality and performance.  
Based on the shear modulus data, the elastic energy stored per unit 
volume and the viscous energy dissipated per unit volume of the scaffold is 
shown in Figure 31.  The detailed derivations are shown in Appendix (1).  The 
constructs with higher collagen content (5% oxygen tension) have higher elastic 
energy storage than the constructs with lower collagen content (20% oxygen 
tension).  The viscous energy loss is higher for constructs grown under 20% 
oxygen tension at lower frequency and drops with frequency.  The viscous 
energy loss is lower for constructs cultured under 5% oxygen tension and is 
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essentially frequency independent.  The high elastic modulus of articular 
cartilage suggests that one of the molecular functions of collagen in cartilage is to 
store elastic energy during locomotion.  In this case, it is easy to see that 
constructs with more ECM have higher energy performance.  
Correlations between construct shear modulus and construct collagen 
content are important to understand the structure-function relationship between 
construct biochemical composition and material properties.  Extensive 
information is available on the material properties of native tissue and different 
groups have proposed  models to explain the viscoelastic behavior of cartilage 
(Mow et al., 1984; Mow and Wang, 1999; Zhu et al., 1993).  Shear modulus 
depends strongly on the tissue collagen content in ovine (Appleyard et al., 2003)  
and bovine cartilage (Zhu et al., 1993).  For cell-polymer cartilage constructs 
(bovine chondrocytes in  poly glycolic acid scaffolds) the complex shear modulus 
depends approximately quadratically on the construct collagen content (Stading 
and Langer, 1999).   
In order to determine the shear modulus of polymer constructs alone, 
unseeded PLLA constructs were soaked in culture medium for 35 days and their 
viscoelastic properties measured.  Unseeded PLLA scaffold had viscoelastic 
properties in the same range as that of the construct (Figure 20).  PLLA is a 
highly crystalline polymer and degrades via random, bulk hydrolysis of the ester 
bonds.  The oligomers closer to the surface degrade faster than the oligomers 
inside the scaffold.  This leads to a delay in the decrease of the mechanical 
properties of the polymer.  PLLA remains stable for over a year in the body.  
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PLLA takes from 9-15 months to register loss in molecular weight and 
mechanical properties (Hutmacher, 2001; Hutmacher, 2000) and is used 
extensively in orthopedic, oral and maxillofacial surgery.  Because of its slow 
degradation time in the body, PLLA is an extensively used biodegradable 
polymer.   
Although unseeded PLLA scaffold had material properties in the same 
range as the constructs, in response to the testing procedure, the scaffold 
disintegrated.  The disintegration of the scaffold at the end of the testing and 
decrease in shear modulus with the frequency indicated possible damage to the 
microstructure of the scaffold.  This is supported by results from other studies 
where after 6 weeks of being soaked in phosphate buffered saline under static 
conditions, PLLA scaffolds with different porosities were too fragile for 
mechanical property testing (Agrawal et al., 2000).  Digestion of the cartilage 
construct in papain at the different times (days 12, 24 and 35) revealed very little 
to no polymer residues in the tissue construct in bioreactor culture.  This 
suggests that the dynamic shear modulus G* of the construct was from the 
presence of ECM in the constructs and not polymer alone.  
To investigate the nature of the relationship between collagen content and 
the dynamic shear modulus for constructs cultured in this study, regression 
analysis was performed between the two quantities (Figure 32).  The analysis 
was performed separately for 5% oxygen tension with decreased hydrodynamic 
loading and for 20% oxygen tension with decreased hydrodynamic loading.  
Different models including linear, second order polynomial, and exponential were 
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used to correlate the construct collagen content with the shear modulus.  
Constructs cultured in 5% oxygen tension with decreased hydrodynamic loading 
showed better fits for the tested models compared to the constructs from 20% 
oxygen tension with decreased hydrodynamic loading environment.  No 
correlations were found for constructs cultured in normoxic environment.  The R2 
values were 0.33 and 0.32 for the exponential and quadratic models respectively.  
In the small range of collagen content produced in tissue engineered cartilage, 
the behavior of exponential and quadratic models is mathematically similar.  
Unlike collagen content, construct GAG content did not exhibit a significant 
correlation with the shear moduli of constructs.  Similarly, construct shear 
modulus did not correlate with total construct matrix. 
About 60-80% of the extracellular matrix in native cartilage is collagen II, 
with the balance of the matrix being GAG.  Collagen is primarily responsible for 
the mechanical integrity of cartilage (Riesle et al., 1998), so it is not surprising 
that an increase in collagen content leads to an increase in G*.  The swollen 
state of the collagen network due to the proteoglycan fixed charge density not 
only provides a pre-stressed state for tissue equilibrium, it also allows for load 
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Thus, the interaction between collagen fibers and GAG molecules is 
multipart and likely contributes to the overall mechanical behavior of constructs.  
This is also supported by observation of an inverse correlation between 
proteoglycan content and dynamic shear modulus in the ovine articular cartilage 
model (Appleyard et al., 2003) and by data demonstrating that the dynamic shear 
modulus of cartilage decreases considerably when the proteoglycans are 
degraded (Zhu et al., 1993).   
Controlled application of mechanical loading and oxygen transport on 
chondrocytes in bioreactor culture increases matrix deposition in cartilage tissue.  
This indicates that the most favorable bioprocessing conditions may be a 
combination of previously known bioreactor conditions.  
Effect of TGF-β1 
Members of the transforming growth factor – β (TGF-β) superfamily are 
thought to play a key role in chondrocyte growth and differentiation.  In one 
bioreactor experiment, addition of 0.2 ng/ml of TGF-β1 to complete DMEM 
increased construct GAG content and cell proliferation two fold in 24 days as 
compared to cultured without DMEM (Figure 22).   
The use of TGF-β1 in culture has diverse effects based on the culture 
environment.  TGF-β has a stimulatory effect on cartilage explants on 
proteoglycan production and cell proliferation.  TGF-β also plays an important 
role in preventing cartilage matrix degradation in the presence of inflammatory 
cytokines such as IL-1 (Grimaud et al., 2002).   
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Our observation that TGF- β1 increases chondrocyte proliferation early 
in culture (Figure 22A, Figure 23A) is in agreement with proliferation studies of 
chondrocytes in the presence of TGF-β1 early (5 days) in culture (Kim et al., 
2003).  However, not much is known about the action of TGF-β1 in long term 3D 
chondrocyte culture.  It has been shown that collagen accumulation can down-
regulate the activity of TGF-β1 (van der Kraan et al., 2002) in chondrocyte gel 
cultures.  Similarly, in alginate encapsulated chondrocyte cultures,  0.1 ng/ml 
TGF-β1 initially increases some proteoglycans like keratan sulfate but as 
collagen production increases, the sensitivity of the cells to TGF-β1 decreases 
(Qi and Scully, 2003).  The proteoglycans decorin, biglycan, and fibromodulin 
regulate the activity of TGF-β proteins by sequestering TGF-β within the extra 
cellular matrix; suggesting inhibition of TGF-β activity after binding to small 
proteoglycans (21).  The high initial cell proliferation in bioreactor culture (Figure 
24A) may be explained by the active TGF-β1 in the media promoting 
chondrocytes to divide rapidly and deposit extracellular matrix early in culture.  
However, it is possible that as the quantity of extracellular matrix increases, the 
activity of TGF-β decreases later in culture.   
Construct GAG deposition (Figure 23B) decreased over time in the 
presence of TGF-β1.  This suggests that long term exposure of chondrocytes to 
TGF- β1 in bioreactors is detrimental to construct development.  This is in 
agreement with observations that short term treatments with intra-articular 
injections of TGF-β for patients with osteoarthritis showed favorable results.  
However, long term intra-articular injections disrupts cartilage homeostasis 
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(Grimaud et al., 2002).  Thus, the beneficial effect of TGF-β on tissue growth and 
repair may be counteracted by tissue degradation seen with longer exposure to 
TGF- β1 in bioreactors and in vivo (8).   
Nitric oxide is believed to be a marker for potential osteoarthritis (Studer 
et al., 1999b).  Increased levels of nitrate/nitrite accumulation in the conditioned 
media from the bioreactor are indicative of NO production by the chondrocytes.  
Increased nitric oxide production by chondrocytes has been observed in the 
presence of TGF-β1 (Vodovotz, 1997).  Nitric oxide and transforming growth 
factor proteins have a complex mechanism of action on chondrocyte metabolism 
(Lane et al., 2000; Vodovotz, 1997).  It has also been shown that nitric oxide can 
modulate proteoglycan synthesis indirectly by decreasing the production of TGF-
β1.  Nitric oxide appears to interfere with the autocrine mechanisms of TGF-β1 
and may potentially diminish the anabolic effects of the growth factor on 
chondrocyte metabolism (Studer et al., 1999a).  Although the mechanism of nitric 
oxide and TGF-β1 is not completely understood, it is possible that these 
interactions play a major role in diminishing matrix GAG deposition in the 
bioreactor.  The decrease in chondrocyte proliferation in the presence of TGF-β1 
over the culture period coupled with increased nitrate/nitrite accumulation 
suggests a specific cell behavior, which indicates that the exposure of 
chondrocytes to TGF-β1 needs to be regulated over the culture period.   
The effect of mechanical and biochemical conditioning is not necessarily 
additive in bioreactor culture as multiple stimuli and pathways can affect 
chondrocyte response.  In this study we found that sequential decrease in 
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hydrodynamic loading increases matrix GAG deposition but in the presence of 
sequential decrease in hydrodynamic loading and TGF-β1, the matrix GAG 
produced after 35 days in culture was lower than that found in sequential 
decrease in hydrodynamic loading alone.  The differential response of 
chondrocytes to shear stress and growth factor can be exploited in a bioreactor 
to modulate chondrocyte proliferation and matrix deposition.  Exposure to TGF-
β1 early in culture to promote chondrocyte proliferation, followed by removal of 
TGF-β1 from culture media and sequential reduction in hydrodynamic loading to 
stimulate matrix deposition appears to be favorable for cartilage construct 
development in bioreactors.  The concentric cylinder bioreactor provides a 
dynamic environment regulating biochemical and mechanical stimuli to enhance 
cartilage construct development.   
In summary, combining decreased hydrodynamic loading with low oxygen 
tension culture increases construct extracellular matrix deposition and enhances 
material properties in tissue engineered cartilage constructs in the concentric 
cylinder bioreactor.  One goal of fundamental tissue engineering research is to 
develop predictive models of tissue growth for different culture environments to 
identify bioreactor conditions that enhance tissue development.  The present 
studies and analyses demonstrate that the concentric cylinder bioreactor is an 
effective tool for cartilage tissue engineering to understand the development of 
cartilage constructs with enhanced material properties for potential in vivo 
application. 
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Perfusion concentric cylinder bioreactor 
The primary design objective of the perfusion concentric cylinder 
bioreactor was incorporation of axial and radial shear stress in the constructs to 
provide – (a) mechanical stimulation to cells inside the construct, (b) minimal 
nutrient gradient through the construct thickness, (c) cell alignment in the 
construct – parallel along the outer surface, perpendicular inside the construct.  
Additionally, the bioreactor was designed in such that way that scale-up and 
preservation of the constructs for downstream processing would be possible. 
These ideas are based on the need to produce cartilage constructs that are 
functionally relevant for in vivo performance.  Existing bioreactor designs such as 
the spinner flask, rotating wall vessel bioreactor, and perfusion bioreactors have 
been described in detail in the background.  In our lab, Dr. Saini had designed 
the concentric cylinder bioreactor to address the requirements of tissue 
engineering such as (a) uniform hydrodynamic loading, (b) large growth area to 
accommodate multiple constructs, (c) simple and scalable geometry.  All of these 
bioreactors have demonstrated that cell-seeded polymers form cartilaginous 
tissue and tissue morphology and extracellular matrix content is dependent on 
the mixing and flow conditions in the bioreactor.   
 Perfusion bioreactors specifically have been designed and utilized 
successfully for cartilage growth by perfusing culture medium through the inner 
porous structure of the scaffolds thereby providing enhanced nutrient transport 
and mechanical stimulation to the cells seeded inside the construct (Davisson et 
al., 2002b; Ratcliffe and Niklason, 2002).  These bioreactors offer a specific 
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advantage of housing each construct in its separate casing and thereby making it 
easy to package and preserve after the culture period.  A major concern cited for 
this bioreactor is that as the tissue develops and more extracellular matrix is laid, 
there will be more resistance to fluid flow through the construct, leading to 
increased pressure drop across the tissue.  This could lead to the formation of a 
necrotic core in the middle of the construct.  
 The current bioreactor design alleviates this by having low shear stress 
environment in the construct and having both perfusion and surface shear to 
mitigate nutrient deficiencies.  As extracellular matrix is deposited and the 
porosity of the construct decreases, the perfusion flow rate can be decreased or 
even completely stopped to prevent pressure build-up.  Because perfusion is not 
the only source of fluid flow, the inner part of the construct will continue to receive 
nutrients because of the presence of surface shear stress.  This concept can be 
exploited to provide different nutrients or growth factor cocktails on the two 
different sides of the construct as the tissue matures.  One obvious example 
would be to provide factors that provide osseous factors on the perfusion end of 
the construct and cartilage promoting factors at the outer cup end of the 
construct.   
 The complex ultrastructure of native articular cartilage has been described 
previously.  The zonal variation of cellular alignment and fibril alignment provide 
cartilage with its unique load bearing capabilities and material properties.  For 
tissue engineered cartilage in bioreactors, it takes up to 7 months in a spinner 
flask to attain compressive load bearing capabilities similar to that of native tissue 
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(Vunjak-Novakovic et al., 1999; Vunjak-Novakovic et al., 2002).  By incorporating 
fluid flow regimes in the perfusion concentric cylinder bioreactor that allow for 
cellular and fibril alignment, we envision to reduce this culture time and also 
tissue engineer constructs that have a spatio-temporal variation within the 
constructs.   
The perfusion concentric bioreactor allows for dynamic seeding of 
constructs.  The purpose of dynamic seeding is to establish a system where 
multiple constructs can be seeded almost identically under flow conditions.  
Dynamic seeding allows for minimal handling of the tissue constructs and 
therefore contamination.  The seeding phase was for four days without perfusion 
flow in the seeding experiments.  This was because seeding using perfusion flow 
would involve flow of the cells through the tubing and the roller pump and this 
could potentially kill the cells.  On day 4, about 10-15% of cells added to the 
bioreactor outer cup were attached to the scaffolds (Figure 22).  This could be 
because of two reasons – (a) the large volume of media in the outer cup, (b) the 
vertical direction of orientation of the bioreactor.  In further modifications of the 
bioreactor design, seeding could be done through the inner perfusion tube rather 
than through the cup to promote cell attachment.   
Monitoring the cell content in the constructs during the seeding phase 
shows that the number of cells attached on days 2 and 3 are similar and there is 
a slight decrease in cell number on day 4 (Figure 22).  Live/dead analysis of the 
constructs after 4 days showed a uniform distribution of cells through the 
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constructs (Figure 23).  These data indicate that even though the seeding 
efficiency was low, the cells were attached to the constructs and were viable.   
Short term construct development 
Construct cell number increased over time in the perfusion bioreactor in 
the short term culture development studies.  The chondrocyte number showed a 
3 fold increase between days 4 and 14.  Perfusion flow at 10 ml/min through the 
constructs was begun at day 4.  The robust increase in cell number even after 
perfusion was begun suggested that perfusion was not causing cell detachment 
from the constructs after day 4.   
An important step in engineering cartilage is producing constructs with 
appropriate chondrocyte density (Freed et al., 1999; Vunjak-Novakovic et al., 
1998; Saini and Wick, 2003).  In cartilage, there is a relatively low cell density 
(10,000 cells/cm3) and an abundance of extracellular matrix.  In order to obtain 
high ECM production in the tissue engineered constructs, high seeding densities 
have been used (Saini and Wick, 2003).  In the perfusion bioreactor, the cell 
density after 14 days is approximately about 3.3 X 106 cells per construct (Figure 
26A).  This is less than the cell density achieved in the concentric cylinder 
bioreactor seeded with 100X106 cells per 16 constructs after 28 days, but the fold 
increase in cell proliferation is higher in the perfusion bioreactor (Saini, 2002; 
Saini and Wick, 2003).   
Based on the cell proliferation data, it seems like a critical cell density 
would be necessary for the chondrocytes to maintain cell-cell contact and 
produce extracellular matrix.  The environment of the perfusion bioreactor seems 
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to be favorable for chondrogenesis even at low cell densities.  Chondrocytes 
seeded on PGA scaffolds showed dependence on chondrocyte initial seeding 
density – 5 X 106 cells/cm3 did not initiate chondrogenesis whereas 10 X 106 
cells/cm3 allowed for chondrogenesis and extracellular matrix deposition (Vunjak-
Novakovic et al., 1998).   
Robust GAG deposition was observed over the short term culture period 
in the constructs (Figure 26B).  The construct GAG content increased about 5 
fold in the span of 10 days in the presence of perfusion.  This supports our cell 
proliferation data that perfusion and surface shear may be a favorable condition 
for extracellular matrix deposition.  The GAG deposition increased between days 
11 and 14 in culture and was highest on day 14.  This is in accordance with 
previous studies were GAG production was highest within 14 days of culture 
(Freed et al., 1998; Vunjak-Novakovic et al., 1998). 
  The construct collagen content did not show any trend over the two week 
culture period but seemed to remain at the same level between days 7 and 14 
(Figure 27C).  Multiple stimuli may be necessary to increase collagen deposition 
in the construct (low oxygen + DHL for example).  Previous studies have shown 
that even in longer culture periods, collagen production remains sub-optimal.  
After 4-6  weeks in culture in a laminar flow bioreactor, PGA scaffolds seeded 
with chondrocytes had only 39% of the levels of collagen measured in native 
tissue (Martin et al., 2000).  Therefore, it is not surprising that collagen levels 
were not high in the short term culture period in the perfusion bioreactor. 
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Kinetics of chondrocyte growth in the perfusion bioreactor 
The values of the construct cell number from the seeding studies and the 
short term construct development studies were used to model the kinetics of cell 
growth in the perfusion bioreactor.  Performing regression analysis on the cell 
number with time as the major variable shows that the cell number follows a 
quadratic model, which accounts for the initial cell number, initial cell growth rate 
and the rate of change of cell growth.  The exponential model was not used in 
this modeling effort because (a) chondrocytes exhibit a slow growth rate, (b) the 
model has to account for the initial cell number in the constructs, and (c) the rate 
of cell growth changes with time in bioreactor culture as shown by the 
experimental data.  
For all experiment groups, the cell growth profiles could be represented by 
the equation 
Y(t) = α- βt+γt2 
Where Y(t) is the cell number per construct in millions at time t (in days), α, β and 
γ are determined from non-linear regression analysis of the data from individual 
experiments.  α represents the initial cell number, β represents the initial cell 
growth rate and γ represents the rate at which cell growth rate changes.  The 










Table 10: Values of coefficients of kinetic models for cell growth 
 
 Alpha Beta Gamma R2 
Expt1 1.29E+06 -1.16E+05 1.80E+04 0.95555 
Expt2 3.15E+06 -9.61E+05 7.69E+04 0.997 
Expt3 1.76E+06 -2.47E+05 1.82E+04 0.7635 



















The model obtained in our work is similar to models published previously 
(Freed et al., 1994c).  These kinetic models attempt to account not only for cell 
proliferation but also parallel ongoing processes like ECM deposition and 
polymer degradation (Freed et al., 1994c).  As new bioreactor design 
requirements are recognized and systems designed, modeling of the tissue 
development data allows us to minimize the number of validation studies 
required before the critical values such as cell density can be obtained.   
Regression analysis is futile in tissue engineering for tissue growth 
processes if the coefficients do not have a physiological meaning.  The values 
from the model show that the initial cell seeding density which is a critical factor 
for achieving the cell density in the final tissue engineered construct can be 
calculated based on the growth rate of the chondrocytes.  Based on the 
experimentally observed seeding efficiency of the bioreactor system, the value of 
the initial number of cells to be added to the bioreactor can then be determined.  
The initial cell growth rate, which represents the growth rate of the isolated 
chondrocytes at zero time, depends on the “health” of the chondrocytes.  In our 
experiments, we isolate cartilage from bovine knee joints and isolate the cells 
using enzymatic digestion.  Handling and storage techniques then become 
critical components of cell sourcing for obtaining a cell suspension with a high 
initial growth rate.  Chondrocytes do not proliferate endlessly, but exhibit 
diminished multiplication with time.  The value of gamma in the regression 
addresses this change in chondrocyte proliferation.   
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One long term construct growth experiment has been carried out in the 
perfusion bioreactor.  Robust cell proliferation and GAG deposition were 
observed in the bioreactor, the collagen values still remained sub-optimal.  The 
shear modulus and the compressive modulus of the constructs were only 10% of 
that of native cartilage indicating that the constructs cultured in the perfusion 
bioreactor for 35 days were not mechanically strong.  While it is hard to draw 
strong conclusions from one experiment, the data suggest that GAG production 
and deposition is upregulated by the combination of perfusion and shear flow and 
additional conditions such as low oxygen tension may be required to increase 
construct collagen production.    
Experimental variability  
Large variances were observed from experiment to experiment in the 
bioreactor studies.  This made it harder to elucidate statistically significant 
differences and draw strong conclusions from the data sets. Some of the factors 
that may have affected the experiments are listed below.  
 Each experiment within a study was carried out using cells obtained from 
a different animal.  The bovine knee joints were obtained from a tissue 
processing facility.  The tissue processing facility obtained the knee joints from 
the slaughter house immediately after slaughter.  The shipping and handling 
processes of the knee joints were beyond the control of the lab, until they were 
delivered to the facility.  The standard order placed for knees was male bovine 
knee joints, 2-3 weeks old. However, these details were hard to verify once the 
knee joint was delivered to the lab.  The tissue was harvested and processed 
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immediately and bioreactor experiments were started within 24 hours of tissue 
isolation.  However, there could be a potential factor that introduced the 
variability in the experiments that may have crept in via the cell source.   
 Another major factor that could influence the results of the experiments is 
the lot of fetal bovine serum used in the culture medium.  It was difficult to order 
the same lot of FBS over the course of all the experiments done, primarily 
because of availability.  This may be have been reverted by ordering large 
quantities of FBS at the start of each study.  
 Differences were also observed under conditions where the results should 
have been similar ideally.  For example, in the decreasing hydrodynamic loading 
studies, for the first twelve days, both bioreactors are operated under similar 
conditions.  However, differences are seen even on day 12.  While it is true that 
these differences were not statistically significant, it does bring up the issue of 
intra-experimental variability.  Some sources of this could be because of 
bioreactor equipment, assays performed and/or because of human error in 
feeding and handling.  Similar differences are seen on day 35, where the 
collagen content is higher for 76 rpm but the differences do not reach statistical 
significance.  The large error bars prevent us from drawing definitive conclusions 
regarding the collagen content in the constructs.  In addition, in the low oxygen 
tension with decreasing hydrodynamic loading has 3 experiments for the 20% + 
DHL condition and 4 experiments for the 5% + DHL condition. This is because in 
one of the experiments, there was a mechanical failure of the bioreactor being 
operated under 20% + DHL on day 6.  
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It is important to recognize that the assays used to measure the 
biochemical content and cell numbers are not necessarily error proof. Papain 
was used to digest the constructs and release the extracellular matrix 
components into the digestate. Papain is a very strong enzyme that could 
potentially damage the ECM components, preventing us from obtaining an 
accurate measure of construct biochemical content. Construct cell number was 
measured using a DNA assay was performed using a fluorometric technique 
where there is a large possibility for background noise, rendering the signal-to-
noise ratio less than accurate.  Samples had to be diluted to minimize this noise.  
But this leads to magnification of error because of introduction of multiplication 
factors to obtain the final cell numbers. Similarly, construct collagen was 
measured by first measuring the hydroxyproline content and then calculating the 
collagen content using a multiplication factor of nine.  This could also lead to 
magnification of error sources.   
It is important to note here that although there are various sources that 
contribute to the variability, some of the results observed in the experiments 
constituting the present research are more toward the exception than the rule.  In 
many published works, researchers have shown a consistency of trends across 
experiments in the same study (Freed et al., 1998; Wu et al., 1999; Dunkelman 
et al., 1995; Carver and Heath, 1999a).  In published works citing the concentric 
cylinder bioreactor, the authors present information on experiment to experiment 
variability across experiments  (Saini and Wick, 2003) and it is clear that the 
bioreactor system has been developed and validated to produce same results 
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experiment after experiment.  Based on the work done by the tissue engineering 
community, it is only appropriate to acknowledge the human error that could 




























CONCLUSIONS AND RECOMMENDATIONS 
 
The current work focuses on bioreactor bioprocessing conditions to 
enhance the material properties and ultrastructure of tissue engineered cartilage 
constructs.  The culture of tissue engineered cartilage constructs was carried out 
using a cell-polymer composite in two different bioreactor configurations. 
 The concentric cylinder bioreactor has been used before and validated for 
tissue engineering of cartilage constructs.  In this work, we have identified 
specific culture conditions that enhance the material properties of the constructs.  
The use of low oxygen tension to modulate extracellular matrix production is well-
documented and this result is reinforced in our studies.  Decreasing the shear 
stress over the culture period leads to increase in construct ECM deposition.  
The response of chondrocytes to hydrodynamic loading schedules is complex.  
This is seen in the response of chondrocyte proliferation and matrix deposition to 
increasing and decreasing hydrodynamic loading.  Both low oxygen tension and 
DHL increase construct GAG by approximately 40%.  Combining the two 
conditions led to an increase in construct collagen content by almost 3-fold 
compared to the control.  The biochemical results were corroborated by 
histological staining.  The shear modulus of the scaffolds cultured in 5% oxygen 
tension with DHL was in the range of native tissue (200-400 kPa).  These results 
suggest that application of simultaneous stimuli are necessary for increasing 
construct extracellular matrix deposition.  
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 The response of chondrocytes to hydrodynamic loading in the concentric 
cylinder bioreactor is complex as shown by these experiments.  Multiple 
biochemical pathways including G-protein signaling and PGE2 synthesis could be 
potentially involved in these pathways. In order to resolve and fully understand 
the effects of varying hydrodynamic loading on chondrocyte metabolism, 
mechantransduction experiments can be undertaken where the force on 
individual chondrocytes can be measured using atomic force microscopy to study 
the effect of different shear stresses.  
 Preliminary work with TGF-β1 in the presence of DHL showed that the 
growth factor increased cell proliferation initially, but there was a drop in 
construct cell number over time.  No significant increase in construct ECM was 
observed in this study.  Thus, the effect of TGF-β1 in the presence of DHL does 
not seem to be synergistic.  The effect of TGF-β1 on construct development was 
not as straightforward as expected.  Understanding the mechanism(s) of action 
of this growth factor are important to harnessing its full potential.  Only one 
concentration of TGF-β1 was studied in this work (0.2 ng/ml).  Future studies can 
use concentrations in a range as wide as 0-50 ng/ml (Blunk et al., 2002).  As 
opposed to having TGF-β1 through the entire culture period, it may be potentially 
beneficial to use TGF- β1 early in culture to increase chondrocyte proliferation in 
the construct.  TGF- β1 can be removed at later times to minimize any negative 
effects of the protein on extracellular matrix deposition.  Additionally, 
investigation into the active and latent stages of TGF- β1 would be useful to 
understand if the effects shown in the studies with exogenous TGF- β1 are 
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because of the growth factor added to culture or that produced by the 
chondrocytes inherently.  Because TGF- β1 is known to have complex modes of 
interaction in the presence of nitric oxide, it may be interesting to see if the 
addition and removal of exogenous TGF- β1 has any effect on construct 
extracellular matrix deposition. 
  The concentric cylinder is a very useful tool for manipulating 
bioreactor conditions for tissue engineering of cartilage.  Based on the 
observations in this study, it would be interesting to investigate the mechanisms 
and signaling pathways that trigger the production and deposition of cartilaginous 
matrix in the constructs.  The effect of varying shear stress as seen in the 
hydrodynamic loading studies is complex.  The constructs exhibit varying kinetics 
throughout the culture period under any given hydrodynamic loading condition.  
Multiple pathways have been postulated to affect the response of chondrocytes 
to shear stress including gap junctions and calcium signaling pathways.  
Therefore, it would be necessary to know if the signaling pathways that affect 
chondrocytes in monolayer culture also affect chondrocytes in three-dimensional 
culture.  For example, it would be interesting to see if intracellular calcium levels 
change in the chondrocytes, when the shear stress is changed in bioreactor 
culture.  Changes in calcium levels are indicative of intracellular response to 
extracellular loading signals.  Additional pathways that could be investigated 
include nitric oxide levels in the cells and the levels of inducible nitric oxide 
synthase levels.  
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 Collagen content increased 3-fold in constructs cultured in hypoxia with 
DHL as compared to normoxia with DHL.  This leads to a 3-4 fold increase in 
construct dynamic shear modulus, confirming our hypothesis that increase in 
construct extracellular matrix content leads to an increase in construct material 
properties.   Low oxygen tension is hypothesized to trigger pathways via the 
hypoxia inducible factor (HIF-1α) (Coimbra et al., 2004; Rajpurohit et al., 1996).  
It would be interesting to see if this factor is increased in articular chondrocytes in 
low oxygen tension.  Quantitative PCR studies should be carried out to see if 
mRNA expression of extracellular matrix proteins is in tandem with HIF-1α.  
Microarray studies may be useful in identifying the genes from the hypoxia 
responsive elements that are affected by low oxygen and varying shear stress 
conditions. 
Little is known about the ultrastructure of tissue engineered cartilage. It is 
hypothesized that shear stress applied on the construct surface is likely to 
promote flattened  morphology of chondrocytes while the cells within the 
construct will continue to be rounded. Fluid flow within and across the construct 
is hypothesized to affect collagen fibril orientation within the tissue.  Organization 
of matrix within the construct is important for enhanced material properties of the 
tissue construct.  Quantitative morphometric analysis can be carried out by the 
use of scanning electron microscopy (SEM), transmission electron microscopy 
(TEM), confocal laser scanning microscopy (CLSM) and stereological methods of 
analysis.  Confocal microscopy should be used to provide visualization and 
quantification of proliferating cells, matrix organization in higher ultrastructural 
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detail. CLSM also will allow for 3D reconstruction of the construct by means of 
optical sectioning.  Use of the disector method with CLSM can be used to  study 
the morphology of the cells within the constructs. The disector method allows for 
optical sectioning of the tissue and reconstruction of the 3-D organization from 2-
D images. The spatial orientation of cells in different layers of the construct can 
be visualized. This information when compared with the cell morphology in native 
tissue may provide information regarding the spatial organization of engineered 
cartilage constructs. It is expected that the cell morphology will vary with the 
bioreactor outer cup rotation rate and the loading regimen. Toluidene blue 
stained sections of the cartilage should be studied for cell density and 
quantitative evaluation of cell morphology should be done by mathematical 
analysis of the intensity functions and cluster densities. This will provide 
information regarding the cell density within the construct and cellular orientation.  
Scanning electron microscopy allows a high spatial resolution, which can 
be exploited to study the fibril orientation of the collagen fibers and proteoglycans 
in the construct. The high magnification capabilities of TEM and SEM combined 
with imaging software (e.g. Image Pro ®) can be used to measure fiber 
diameters, lengths and periodicity in the constructs. This in turn can be correlated 
with the bioreactor operating conditions.  In order to study the collagen 
component alone, the proteoglycans can be digested by hyaluronidase and the 
collagen fiber microstructure studied.  Microscopic  stereological techniques can 
be used to measure the collagen volume density, surface density, and length 
density of the collagen fibers. The matrix fibril orientation is expected to vary with 
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internal flow within the construct.  Samples for stereological analysis can be 
photographed under transmission electron microscopy. The length of the fibers 
and their volume and surface densities can be evaluated by means of 
mathematical calculations. Since the stereological method is based on statistical 
analysis, it gives a 3D representation of the collagen network in the cartilage 
construct. These studies will help to obtain correlations between the structure of 
the construct and its biochemical composition and mechanical properties of the 
construct. The material properties can be directly related to the fibrillar 
networking and the organization. Comparing the structure of native cartilage and 
engineered tissue will allow us to identify the relative merit of engineered 
constructs. Prior studies have shown that the culture environment has an effect 
not only on the biochemical  composition but also on the fibril orientation. Much 
emphasis has been laid in the literature on the zonal organization of the tissue, 
cell shape and cell biosynthetic  activity specific to the zone of the tissue [22, 23].  
Quantitative morphometric analysis of samples cultured under bioreactor 
conditions outlined above, and their correlation with (a) mechanical properties, 
(b) biochemical composition, (c) integrability with native tissue will help identify 
bioreactor-operating conditions that promote matrix deposition and organization.  
Thus, the relation between cartilage ultrastructure, biochemical composition, and 
function can be established. 
A perfusion concentric cylinder bioreactor was designed to incorporate 
axial and radial fluid flow through the construct.  The bioreactor prototype was 
built and seeding studies were carried out.  While the seeding efficiency in the 
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bioreactor after 4 days was only 10%, most of the cells in the construct were 
viable.  The perfusion bioreactor showed robust matrix deposition in two-week 
construct development studies and the kinetics of chondrocyte proliferation 
followed previously established models.  The preliminary long term experiment 
(35 days) also showed robust cell proliferation and GAG deposition in the 
construct.  The material properties of the construct after 35 days remained at 
10% of the values of native tissue. 
 Detailed studies involving different seeding methods should be carried out 
in the perfusion bioreactor to promote construct seeding efficiency.  Some of the 
experiments that may be carried out here include seeding via the inner tube as 
opposed to the outer cup and use of a spinner flask to improve seeding efficiency 
and then transfer of constructs to the perfusion systems.  The bioprocessing 
conditions tested in the concentric cylinder bioreactor such as low oxygen 
tension and varying hydrodynamic loading can be used in the perfusion 
bioreactor to enhance construct material properties.  The ultrastructural studies 
outlined above will be useful in evaluating the ability of the perfusion bioreactor in 
producing constructs with an ultrastructure similar to that of native tissue.  
Computational fluid dynamic models can be used to understand the complex 
hydrodynamic environment in the perfusion concentric cylinder bioreactor.   
 In summary, the current research has  identified bioreactor bioprocessing 
tools for improving construct material properties.  Using the information obtained 
from these conditions, further experiments can be designed using statistical 
methods to improve the functionality of tissue engineered constructs.  Thus,  this 
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research has not only identified important culture conditions for tissue 
engineering but has also increased the database of available information to allow 























F is the shear force applied on the tissue construct with cross sectional area A. 
Shear Stress F
A
τ =  
Shear strain D
H
υ =  
Shear rate V
H
υ =  
Oscillation 
 
Shear stress  
* *
elastic stress = sin
viscous stress = cos
ie iδτ τ τ τ τ
τ τ δ
τ τ δ




Shear strain * / 2ie πυ υ −=  



























τ τ τη η η η




′ ′′ ′ ′′= + = = + 
 





Instantaneous viscous energy loss and elastic energy storage 
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Average power dissipated per volume = 2η υ τ υ′ ′=  
Maximum elastic energy per volume = 




Viscous stress = rate of energy dissipated per unit volume 




















EXPERIMENT DATA - CONSTRUCT BIOCHEMICAL COMPOSITION 
Decreasing Hydrodynamic Loading 
Cell/Construct (Millions)      
76 rpm 12 d 24 d 35d DHL 12d  24d 35d  
expt 1 9.002727 6.941688 51.75175  11.58818 7.286688 15.9711 
 18.63974 31.09383 84.93974  2.029851 2.637195 39.1461 
 4.967159 18.34134 9.95422  19.9122  11.92549 
   45.48011  14.99464  5.932753 
        
expt 2 14.6402 10.90525 7.184445  40.5889 8.024798 10.9634 
 34.26547 7.206993 7.749422  7.552373 8.016613 38.78762 
   8.329706  7.492206  21.81244 
       7.954242
expt 3 7.033751 6.938739 9.336272  7.305979 7.826077 7.95316
 8.785054 8.370216 7.912999  7.780863 7.008314 7.79556
   7.78767  7.568608  7.2463 
       7.130368 
expt 4 8.709093 6.609613 7.329228  7.885474 0.973013 7.148074 
 9.15027 9.374226 8.046793  8.446455 0.948828 7.403886 
 8.399734  5.996229  7.633217  5.876434 
       6.787579 
        
        
n 10 9 13  13 8 16 
Average 12.35932 11.75354 20.13835  11.59838 5.340191 13.11466 
SEM 2.730229 2.709912 6.856704  2.696831 1.14005 2.731467 
        
Construct GAG Content(µg)      
76 rpm    DHL    
 12 d 24 d 35d  12d  24d 35d  
expt 1 2117.028 1893.459 3160.35  1669.89 1967.982 9379.798
 1446.321 1669.89 2638.689  1893.459 2638.689 9842.479
 1781.675 1781.675 2899.52  1781.675 2303.336 7487.014
        
        
expt 2 343.1439 212.8995 5020.802  3112.579 2577.049 6351.343
 991.8612 325.611 5087.45  4374.435 1288.524 10136.91
 738.8865 4709.779 5184.45  4954.154  4954.154
       4976.37
expt 3 4931.938 4865.29 5702.895  4976.37 5131.882 4954.154
 6610.174 7344.638 6653.378  5242.961 6869.396 6653.378
   6999.008  5242.961  6696.581
       6221.34
expt 4 6437.359 7344.638 6610.174  6178.136 6739.785 7128.619
 6307.748 6523.766 6264.544  5918.914 6782.989 6869.396
 8035.898  5659.691  6566.97  8035.898
       7690.268
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n 12 10 12  12 9 15
average 3612.912 3667.164 5156.746  4326.042 4033.292 7158.514
SEM 824.7847 891.4313 434.9335  510.5659 772.7466 429.4631
        
        
Construct Collagen 
Content(µg)      
76 rpm 12 d 24 d 35d  12d  24d 35d  
expt 1 163.8468 2075.393 764.6184  273.078 436.9248 655.3872
 436.9248 764.6184 436.9248  710.0028 928.4652 600.7716
 2621.549  5352.329  983.0808 5516.176 3058.474
     2621.549 1693.084  
        
expt 2 3604.63 2293.855 7952.031  600.7716 764.6184 5898.485
 2785.396 1474.621 3550.014  2403.086 2949.242 5734.638
  4423.864   1310.774 2184.624 1201.543
        
expt 3 4205.401 928.4652 4696.942  7646.184 2184.624 710.0028
 542.8791 196.6162 7799.108  6390.025 1365.39 240.3086
   3593.706  3702.938 7919.262 142.0006
        
expt 4 5439.714 2173.701 3866.784  2020.777 3189.551 3582.783
 8956.958 4631.403 2479.548  3047.55 316.7705 775.5415
   382.3092  1245.236 415.0786 218.4624
        
        
n 9 9 11  13 13 12
average 3195.255 2106.948 3715.847  2535.004 2297.216 1901.533
SEM 940.9868 513.9881 884.5971  749.4464 742.8471 710.2726
        
        
        



















Increasing Hydrodynamic Loading 
Construct Cell Number (Millions)      
19 rpm 12 day 24 day 35 day IHL 12 day 24 day 35 day 
expt 1 4.041732 6.98837 10.08198  2.748554 7.272318 11.80115 
 1.952315 13.07617 18.00671  7.554297 8.772629 9.397871 
 1.97338 14.99442 10.46235  3.840386 10.85885 10.63656 
       7.452111 
expt 2 6.41647 12.05533 12.47236  7.575284 4.11067 11.30382 
 1.109278 11.10958 6.359932  8.869518 5.574708 11.75474 
 2.922893 16.02163 13.9335  8.429943 6.742922 8.961646 
 1.867555      10.36334 
       10.45478 
expt 3 6.879032 3.239386 27.39406  7.488024 5.524953 7.970855 
 7.737782 7.2843 26.93971  6.868618 8.069619 8.277957 
 0.76026 15.67181 8.588147  5.426296 7.196224 19.27514 
 2.46501    2.599178  6.068605 
       11.77562 
expt 4 1.58841 6.659525 24.739  5.350973 1.239091 16.38967 
 3.662963 3.009476 17.05181  5.065799 5.162855 2.854039 
 0.083766 3.128453 17.34055  6.025555 4.795839 15.40025 
     3.490597  16.79887 
       14.27631 
n 14 12 12  14 12 19 
Average 3.104346 9.436538 16.11418  5.809502 6.276723 11.11649 
SEM 0.634851 1.440427 1.984054  0.555784 0.712737 0.921323 
        
Construct GAG Content (µg)      
19 rpm 12 day 24 day 35 day IHL 12 day 24 day 35 day 
expt 1 3134.294 3585.461 6170.615  567.252 1364.204 10186.66 
 1509.104 4446.63 6341.861  4830.286 1461.353 5108.561 
 2299.47 6160.735 3089.836  1010.186 5385.189 5811.657 
       3295.66 
expt 2 1138.62 4517.433 4520.727  801.0685 3723.775 4143.656 
 1372.437 4398.879 2828.027  5887.4 1108.982 5770.492 
 1069.463 7048.25 9521.436  2304.41 2271.478 4879.684 
 1709.989      2072.24 
       4150.243 
expt 3 3876.908 1922.4 5483.985  1919.106 1336.212 2711.119 
 3353.291 3918.073 13678.26  1639.185 3559.115 4456.509 
 1326.332 2250.072 23409.64  2353.808 876.8118 4664.804 
 2516.82    1691.876  3350.821 
       7549.638 
        
Expt 4 4530.606 5307.799 8784.584  4716.671 806.0083 3110.418 
 412.472 1438.301 6262.001  5487.278 1104.042 8333.417 
 3796.225 1882.881 4197.171  4631.048 2338.988 8712.134 
     1357.618  7895.423 
n 14 12 12  14 12 19 
Average 2289.002 3906.409 7857.346  2799.8 2111.346 5344.619 





Construct Collagen Content (µg)      
19 rpm        
 12 day 24 day 35 day IHL 12 day 24 day 35 day 
expt 1 1170.294 528.7734 923.9785  1027.69 1105.867 970.7274 
 1062.261 1899.813 1142.795  194.8526 1041.833 2655.26 
 816.731 1091.332 1798.458  748.7683 1279.113 964.8347 
   2362.195    7160.048 
       985.2628 
        
expt 2 1414.646 1098.01 544.0945  1822.815 1089.368 1802.387 
 1447.252 1354.54 1466.894  2172.842 912.1931 1055.975 
 2134.343 1546.643 867.8012  955.4063 1343.147 1277.542 
 1280.292      4160.653 
       1380.861 
        
expt 3 1960.312 1213.9 1346.683  1248.078 1908.063 2570.404 
 879.5867 872.1226 2016.882  1853.85 1239.043 1601.248 
 875.2653 1172.651 1804.744  428.2043 1122.367 914.5501 
 924.7642    1097.617  1566.678 
       1243.757 
        
expt 4 1446.466 698.4837 1455.109  1029.262 1625.605 1360.825 
 540.5588 423.883 2108.022  1048.511 1247.685 2736.579 
 621.0927 977.7987 2724.008  1088.582 1469.252 2027.881 
     1077.975  1437.038 
n 14 12 12  14 12 19 
Average 1183.847 1073.163 1581.666  1128.175 1281.961 1993.29 
SEM 124.9711 120.7671 174.9198  142.2143 79.76777 343.742 
        
        
        
        
        























Low oxygen tension with decreasing hydrodynamic loading 
Construct Cell Number (Millions)      
20% oxygen + 
DHL 12 day 24 day 35 day 
5% oxygen + 
DHL 12 day 24 day 35 day 
expt 1 64.48086 53.36177 43.96944  1.519816 4.835764 12.97759
 55.02732 38.00494 60.3043  2.599052 2.59235 27.28881
 67.73112 35.79288 57.24447  2.224082 42.44328 19.10566
 25.15386 30.07108 63.33123  1.814682 29.65581 72.12816
   53.09127    104.0206
   60.90484     
expt 2 4.898804 17.7322 22.09007  27.35551 19.45642 92.53381
 8.161651 18.50693 19.91592  40.77179 13.14354 101.4078
 15.51148 28.30995 7.95647  36.12598 14.06828 92.35054
 2.993293 16.74764 2.800421  29.35031 13.03769 108.5773
  23.42123 12.85186    5.054831
   21.57774     
expt 3 1.003678 28.18375 1.475205  1.175277 0.427827 0.711105
 1.305476 24.98347 0.456972  0.580195 0.481056 0.437724
 16.94632 18.91651 0.408311  0.422754 0.537113 1.57308
 18.55625 17.95076 0.934458  0.422338 1.907174 19.01722
  20.98409 1.837804    19.52914
   1.604889     
expt 4     46.52157 27.07726 21.18895
     34.28808 37.83671 27.16644
     23.95476 37.68096 28.98539
     21.29424 39.36394 4.567787
      30.14248 0.64466
      23.4334  
        
n 12 14 18  16 18 20 
Average 23.48084 26.64051 24.04198  16.90128 18.7845 37.96333
SEM 7.158492 2.960789 5.879337  4.033803 3.558555 8.953166
        
Construct GAG Content (µg)      
20% oxygen + 
DHL 12 day 24 day 35 day 
5% oxygen + 
DHL 12 day 24 day 35 day 
expt1 11978.2 18814.31 35887.91  2007.482 2881.17 2714.436
 5215.451 28851.72 23056.03  2621.064 2841.154 3834.891
 19834.72 34874.16 30865.87  2747.783 35027.56 3894.915
 3521.43 52554.68 27604.54  2761.121 3721.511 26497.43
  1949.578 33933.78    39669.44
   34714.1     
expt 2 1023.046 1660.037 1666.471  20975.18 31699.54 34980.87
 1164.599 2934.018 913.6635  39362.65 29765.42 36194.7
 2882.544 2766.728 1434.838  37848.7 34167.21 35527.76
 1614.997 3428.059 3313.639  31045.94 32553.22 36181.36
   1927.449    1415.535
   2354.936     
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expt 3 1472.205 3641.479 1687.352  302.4097 1376.93 1241.81
 960.39 2961.203 1900.772  1524.917 1177.468 894.3607
 2861.162 660.2681 1827.409  1106.691 1595.694 18474.17
 7543.063 1740.707 1920.78  1396.232 1666.471 20101.5
  4188.368 820.3331    20368.27
   2670.214     
      
expt 4     19494.58 20721.75 13885.64
     18881 19567.95 15606.34
     18934.36 18480.84 1415.535
     13132 13038.63 1621.431
      17333.71 598.3852
      20381.61  
n 12 14 18  16 18 20
Average 5005.984 11501.81 12107.64  13383.88 15999.88 15755.94
SEM 1645.173 4315.91 3393.035  3231.13 2877.647 3268.268
 
Construct Collagen Content (µg)      
20% oxygen + DHL   5% oxygen + DHL   
expt 1 12 day 24 day 35 day  12 day 24 day 35 day 
 1693.084 5002.789 5363.252  994.0039 17902.99 9918.193
 6848.796 4150.786 6859.719  6237.102 9743.423 2250.163
 12528.82 3080.32 6127.87  10103.89 10868.5 17739.15
 3451.706 1776.045 199.9188  1769.545 17804.69 15805.75
  780.1596 199.9188   17673.61 13948.82
   599.7564     
        
expt 2 3598.538 393.2323 2548.965  7471.414 15095.75 17444.22
 199.9188 399.8376 999.594  13074.97 17870.22 12845.59
 299.8782 299.8782 299.8782  16351.91 17892.07 13479.13
 5347.828 999.594 199.9188   349.8579 6717.719
   1728.763    199.9188
        
expt 3 789.0251 199.9188 2240.004  17859.3 349.8579 149.9391
 292.5599 1832.193 854.0384  449.8173 249.8985 199.9188
 1028.392 2242.959 2724.648  199.9188 2417.313 149.9391
 1554.409 2157.26 1575.095  749.6955 249.8985 4198.295
  1190.925 1270.715    149.9391
        
expt 4     1424.382 2627.128 3723.489
     1675.57 3891.933 2739.424
     1604.646 3286.127 2086.336
     6049.192 3368.871 3593.462
      2325.703 3094.042
        
n 12 14 18  16 18 20 
Average 3136.079 1750.421 2112.003  5734.357 7998.214 6521.672
SEM 1053.489 382.4086 541.3063  1558.069 1657.98 1427.147





14 day construct Biochemical Composition  
Construct Cell Number 
(Millions)    
 4day 7day 11day 14 day  
Expt 1 0.069215 0.106544 1.691224 4.033348  
 1.248966 0.367764 2.042982 3.357293  
 0.332375 0.132414 1.729227 7.053816  
 2.004355 2.292804  4.150439  
      
Expt 2 1.999792 0.613806 3.148085 3.038532  
 0.844897 0.123081 1.771753 2.291915  
 0.560352 1.330519 3.902716 3.05397  
 1.382626 0.86415  1.751866  
      
Expt 3 0.574147 0.51832 0.661408 1.861771  
 1.822058 0.571758 1.467725 1.947975  
 1.799932 0.95991 1.771423 1.944853  
      
Expt 4 1.003232 0.259024 3.553695 3.605172  
 0.242039 2.286093 1.189228 5.381606  
 2.648649 3.06833 0.583269 2.362878  
  1.002954    
      
Average 1.180903 0.966498 1.959395 3.27396  
SEM 0.210671 0.234512 0.305841 0.405492  
      
Construct GAG Composition 
(µg)    
 4day 7day 11day 14day  
Expt 1 2607.726 2714.436 2581.048 4755.264  
 3161.284 3134.606 3394.712 4948.676  
 3074.582 3194.631 2707.766 8756.889  
 3035.866 1694.021  9297.109  
      
Expt 2 2127.253 2899.932 1571.591 1948.392  
 1805.303 1390.346 1767.146 1390.346  
 2024.706 2062.863 2065.248 2062.863  
 4171.037 1793.379    
      
Expt 3 1545.359 686.826 2353.81 15625.29  
 2961.937 1201.946 2081.941 23566.72  
 2275.111 1108.938 1874.463 20018.12  
    833.1133  
      
Expt 4 1343.183 25407.12 1445.196 28886.93  
 6795.258 3383.46 4925.003 969.1318  
 6103.83 4006.878 3087.921 21749.49  
      
Average 3073.745 3905.67 2487.987 10343.45  
SEM 432.5226 1618.316 280.1905 2601.543  
 155
      
Construct Collagen Composition (µg)   
 4day 7day 11day 14day  
Expt 1 620.3696 510.5837 596.6783 1121.428  
 302.4912 779.492 1138.647 924.082  
 542.3349 311.406 1014.084 1023.427  
 612.3707 896.6661  1243.792  
      
Expt 2 779.6141 1276.581 1376.598 1402.976  
 1460.311 248.0257 1358.829 1317.797  
 1082.777 5762.66 1966.071 2035.13  
 1435.948 638.9318  1024.831  
      
Expt 3 886 736.6278 1341.794 1272.246  
 1513.555 1207.767 347.1261 607.547  
 862.0451 782.9113 810.2051 823.5773  
  1224.192    
      
Expt 4 729.6059 1836.929 2243.222 775.7673  
 1374.949 1441.627 198.8114 1995.197  
 377.9614 7818.252 2748.066 1600.993  
      
Average 898.5952 1698.177 1261.678 1226.342  
SEM 109.9487 554.2496 219.962 113.8706  
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35 day constructs 
Construct Cell Number 
(millions)    
 4 day  12 day 20 day 28 day 35 day 
 0.22786 5.811075 7.432704 3.369997 3.709642
 0.927246 7.70632 7.305018 6.251951 1.862018
 1.291038 5.401631 6.971898 9.364972 6.565469
      
Average 0.815382 6.306342 7.23654 6.328973 4.213743
SEM 0.311968 0.709898 0.137359 1.731029 1.920176
      
Construct GAG composition 
(µg)    
 4 day  12 day 20 day 28 day 35 day 
 4294.827 6031.048 5681.822 5288.015 4914.021
 3947.252 5283.061 5041.988 4774.496 3921.659
 5117.943 6725.371 5794.103 6081.409 12150.34
     5366.446
      
Average 4453.341 6013.16 5505.971 5381.307 6588.116
SEM 347.1185 416.4551 234.2448 380.146 1878.461
      
Construct Collagen Composition (µg)   
 4 day  12 day 20 day 28 day 35 day 
 744.3329 449.1628 616.164 378.2322 750.8424
 983.1626 1007.18 417.0644 599.7781 917.1702
 813.6923 467.1199 283.0594 1899.874 1090.456
     1414.358
      
Average 847.0626 641.1543 438.7626 959.2946 1043.207
SEM 70.93445 183.0864 96.76909 474.6182 141.8179
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